MediWales Review: BioWales 2013

BioWales Brochure 2013 Developing Tomorrow’s Healthcare Solutions Celebrating Success MediWales Innovation Awards Winners 2012 SUPPORTED BY THE WELSH GOVERNMENT

SPRING 2013 BIOWALES BROCHURE

Welcome to BioWales This spring’s edition of The Review incorporates the official brochure for Welsh Government’s BioWales conference 2013.

This issue contains everything you need for BioWales 2013, including the conference programme and details of workshops, exhibitors and speakers in addition to an update on Welsh Government’s recent activities.

The spring 2013 Review also showcases the innovations and expertise of the life science sector in Wales, featuring the NHS and industry winners of MediWales’ Innovation Awards 2012.

BioWales 19-20th March 2013: Delivering Tomorrow’s Health Solutions Wales Millennium Centre, Cardiff Bay BioWales, one of the UK’s largest life science conferences and brokerage events hosted outside London, returns to Cardiff’s Millennium Centre to celebrate its 11th year. Focussing on links between industry, academia and the NHS, BioWales 2013 brings together an unparalleled conference programme with world-class guest speakers, researchers and companies.

Sector experts will come together to share their expertise in presentations and workshops, with keynote speaker Professor Sir Christopher Evans, Chairman of Arthurian Life Sciences and presentations from GE Healthcare, NICE, Microsoft and Johnson & Johnson.

The two-day conference plays host to a brokerage event with pre-arranged, oneto-one meetings and discussions enabling potential collaborations.

With over 500 delegates attending last year and 35 exhibitors attending this year, BioWales is an unmissable opportunity to learn, network and promote. It culminates in the gala dinner taking place on the night of 19th March, which promises to be a vibrant evening of celebration and entertainment.

Welsh Life Science Wales’ life science sector comprises over 250 companies, employing around 15,000 people and contributing significantly to the Welsh economy. With the recent launch of a £100 million fund, strong medical technology sector and burgeoning biotechnology sector, Wales is establishing itself as a life science cluster that national and global healthcare markets cannot ignore.

MediWales Innovation Awards 2012 MediWales’ 7th Annual Innovation Awards dinner and ceremony took place on 11th December in Cardiff’s magnificent City Hall, preceded by the brand new UK HealthTech conference. With over 450 delegates, these two events highlighted and celebrated the current strength of Welsh life sciences and hosted the premier of MediWales’ film “Unrivalled Connectivity”.

BioWales 2013

Conference Brochure

Contents 4-5

Welsh Government Life Science Sector Panel Foreword Life Sciences: Welsh Government Supports Business to Transform Global Healthcare

6-13

Speaker Profiles

15-19

Conference Programme

20-21

Exhibitor Floor Plan

22-23

Exhibitor Profiles

25-35

MediWales Innovation Awards 2012

36-38

MediWales UK HealthTech Conference

39

Who are we?

MediWales MediWales is the industry-owned forum for Wales, established to service the life science sector and part-funded by the Welsh Government.

We work with academics, businesses, SUPPORTED BY THE clinicians and business support organisations to facilitate their collaboration, improve healthcare systems in Wales and advise government on industry-led strategy. MediWales can assist international contacts on sourcing commercial and collaborative research and development partners in Wales, helping our members to build relationships both at home and abroad.

Scan here to view MediWales’ publications

MediWales is a founding member of Medilink UK, the network of regional medical technology organisations that represents the interests of around 3000 organisations across the UK.

WELSH GOVERNMENT

The Welsh Government is a democratically elected body established in May 1999.

With devolved powers, it is responsible for developing and implementing policies in Wales on a broad range of economic issues, including economic development, education, the environment, agriculture, housing, roads and transport.

Forum Manager:

gwyn.tudor@mediwales.com

Project Manager:

debbie.laubach@mediwales.com

Project Coordinator: charlotte.tyson@mediwales.com and Editor Web:

www.mediwales.com

Telephone:

+44 (0)29 2047 3456

7 Schooner Way, Atlantic Wharf, Cardiff CF10 4DZ MediWales Chairman: Mr Greg Baily, Huntleigh The MediWales Review is designed by Teamworks Design & Marketing

SPRING 2013 BIOWALES BROCHURE

Welcome to BioWales 2013: Celebrating Success and Looking to the Future of Healthcare In BioWales’ eleventh year, we are bringing together leaders from the healthcare community – within industry, the NHS and our world-class universities – to look at how Wales can provide solutions to global healthcare problems.

This collaborative approach epitomises the life sciences ecosystem we are developing here in Wales, and showcases where we’re going as a sector – working together to create health and wealth for Wales.

We’ve made an excellent start to delivering our life sciences strategy by raising the profile of the sector on the international stage and developing relationships within a range of diverse markets, including China and the UAE. Nurturing these new relationships will help us to generate exciting trade opportunities for Welsh companies, grow life sciences businesses and create jobs and wealth in Wales.

2013/14 promises to be even more exciting with the Wales Life Sciences Investment Fund making its first investments and the development of our ecosystem gaining pace.

Join us in BioWales 2013 to find out how you can help us deliver the next stage of our life sciences growth plan.

Welsh Government Life Sciences Sector Panel

4

The Wales Life Sciences Investment Fund: Delivering Our Vision for Growth

“

At BioWales 2012, I talked to you about our vision for a new strategy for the sector in Wales. A key part of that strategy was launching a fund to meet the specific needs of life science businesses, enabling companies to realise their potential and deliver rapid growth. I’m delighted to reveal that our vision is becoming a reality with the official launch of the Wales Life Sciences Investment Fund here at BioWales 2013.

This year, we will make our first investments and provide the funding needed for entrepreneurs and enterprising scientists in Wales to turn their exciting ideas into reality.

At BioWales 2013, we will outline the Wales Life Sciences Investment Fund and demonstrate how it will help us realise the potential of the sector.

”

Professor Sir Christopher Evans OBE Chairman, Arthurian Life Sciences

Croeso i BioCymru 2013: Dathlu Llwyddiant ac Edrych ar Ddyfodol Gofal Iechyd Eleni, mae cynhadledd BioCymru yn dathlu ei phen-blwydd yn 11eg oed. Dyma gyfle i arweinwyr y gymuned gofal iechyd ddod ynghyd - arweinwyr y diwydiant, y GIG ac ein prifysgolion rhagorol – i chwilio am ffyrdd i helpu Cymru i gydweithio i ateb y problemau sy’n wynebu’r byd gofal iechyd.

Mae cydweithio fel hyn yn fynegiant o’r ecosystem gwyddorau bywyd yr ydym yn ei datblygu yma yng Nghymru ac yn dangos i ba gyfeiriad y mae’r sector yn mynd – cydweithio i greu iechyd a chyfoeth i Gymru.

Rydym wedi gwneud gwaith rhagorol ar roi’n strategaeth gwyddorau bywyd ar waith trwy godi proffil y sector ar y llwyfan rhyngwladol a datblygu cysylltiadau o fewn amrywiaeth o farchnadoedd gan gynnwys Tsieina a’r Emiraethau Arabaidd Unedig (UAE). Drwy feithrin y cysylltiadau newydd hyn, byddwn yn gallu creu cyfleoedd busnes cyffrous gyda chwmnïau o Gymru, ehangu busnesau gwyddorau bywyd a chreu swyddi a chyfoeth i Gymru.

Mae 2013/14 yn argoeli bod yn flwyddyn gyffrous iawn gyda Chronfa Buddsoddi Gwyddorau Bywyd Cymru yn gwneud ei buddsoddiadau cyntaf a’r gwaith yr ydym yn ei wneud ar ddatblygu’n ecosystem yn codi stêm.

Ymunwch â ni yn BioCymru 2013 i ddysgu sut i’n helpu i gynnal cam nesaf ein cynllun i ddatblygu’n gwyddorau bywyd.

Panel y Sector Gwyddorau Bywyd Llywodraeth Cymru

Cronfa Fuddsoddi Gwyddorau Bywyd Cymru: Gwireddu ein Gweledigaeth i Ehangu

“

Yn BioCymru 2012, bûm yn trafod ein gweledigaeth ar gyfer strategaeth newydd i’r sector yng Nghymru. Rhan bwysig o’r strategaeth honno oedd lansio cronfa i ddiwallu anghenion penodol busnesau gwyddorau bywyd, gan alluogi cwmnïau i wireddu’u potensial a thyfu’n sylweddol.

Pleser o’r mwyaf yw gallu cyhoeddi bod y gwaith caled rydym wedi bod yn ei wneud wedi talu ar ei ganfed a byddwn yn lansio Cronfa Fuddsoddi Gwyddorau Bywyd Cymru yn swyddogol yn BioCymru 2013.

Eleni, byddwn yn gwneud ein buddsoddiadau cyntaf ac yn rhoi’r cyllid sydd ei angen ar ein entrepreneuriaid a’n gwyddonwyr yng Nghymru i droi eu syniadau cyffrous yn realiti.

Yn BioCymru 2013, gallwch ddysgu mwy am Gronfa Fuddsoddi Gwyddorau Bywyd a sut y byddwn yn ei defnyddio i wireddu potensial y sector.

”

Yr Athro Syr Christopher Evans OBE Cadeirydd, Arthurian Life Sciences

5

SPRING 2013 BIOWALES BROCHURE

Life Sciences:

Welsh Government Supports Business to Transform Global Healthcare This year, we are showcasing industry players who are delivering healthcare solutions to drive forward the health and wealth agenda, and demonstrating why Wales is a prime destination for investors.

Investing for Growth The Welsh Government has delivered on its promise to drive forward growth in the sector in 2012/13. We have offered investment worth over £6.5 million to a diverse range of life sciences businesses, from SMEs with ambitious expansion plans, to multinationals looking to cement their presence in Wales.

We will build on this momentum by offering further investments and by stepping up our international trade programme. The £100 million Life Sciences Wales Fund managers will also make investments to catapult life sciences in Wales into the big league.

6

Working Together to Develop Tomorrow’s Healthcare Solutions Phenomenal Welsh successes in 2012/13 include: GE Healthcare officially opened its Cell Science Laboratories at the Maynard Centre in Cardiff in December 2012. The Centre is a key research and development facility for GE Healthcare Life Sciences. The new laboratories are a result of a £3 million investment by the Life Science business for GE Healthcare to create a world-class centre of excellence in Cell Sciences in Cardiff.

Haemair continued working with academics at Swansea University to develop respiratory aids which mimic the performance of healthy lungs. The project aims to develop a prototype respiratory aid to improve patients’ quality of life and is funded by the Welsh Government’s Academic Expertise for Business programme.

As BioWales celebrates its 11th year, the Welsh Government reveals its next steps for supporting life sciences growth.

Q Chip was awarded a grant of £250,000 from the governmentbacked Technology Strategy Board towards the cost of developing an innovative scaled-up sustainedrelease pharmaceutical manufacturing process. Q Chip has developed an entirely new approach to the manufacture of sustained-release drug formulations for subcutaneous injections.

EKF Diagnostics won the best use of AIM category at the Alternative Investment Market Awards. EKF Diagnostics specialises in the development, production and distribution of near patient analysers for use in the detection and management of diabetes, anaemia, lactate and kidney disease.

Biotec Services International was named the best international business in the UK at the British Chambers of Commerce Chamber Awards. The Bridgend-based company is recognised as a global leader in temperature controlled pharmaceutical services.

£

6m

£2.2m

Major employers in Wales Include:

£1m

£6m

Biomet UK

£1.25m

2.2m

Alere

Nice-Pak

GE Healthcare

Siemens

Norgine Penn Pharma

ConvaTec

Recent Funds Raised Include: Medaphor £1m Clinithink £1.25m Nanotether Discovery Services £2.2m Wockhardt £6m

Academia and Industry – Collaborating for Growth Our academic institutions continued to deliver world-class research and built on an already impressive repertoire of projects to grow the sector in Wales in 2012/13:

Medical Research Council Investment in Swansea University In August 2012, the Medical Research Council announced £19 million investment to establish four E-health research centres of excellence. Swansea University will become home to one of four centres of excellence in E-health research in the country, with around £4.5 million of the total invested in Swansea University’s first MRC Centre.

European Cancer Stem Cell Research Institute at Cardiff University A team at the School of Biosciences has identified a weakness in breast cancer stem cells, the cell type responsible for tumour spread and relapse. Dr Richard Clarkson is leading the research team and said:

“We believe we have found a crucial ‘Achilles heel’ in breast cancer stem cells. We can almost completely shut down their ability to spread the disease through the body through secondary tumours”.

Life Science Wales at Swansea University The Life Science Wales project, backed by the Welsh Government’s European funded Academic Expertise for Business programme, is an innovative collaboration between academia, business and the NHS in Wales which will consider how life sciences can make an even greater contribution to the economy.

Life Science Wales, led by Professor David Ford, brings together Swansea and Cardiff Universities with other academic institutions, the life sciences commercial sector and the NHS to encourage innovation, promote collaboration, identify opportunities, and share knowledge and problem solving within the sector.

Spotlight on: Wound Care in Wales Wound healing employs around 1600 people in Wales with a commercial turnover in excess of £70 million annually and a research income over £1.5 million. The total spend on wound healing in Wales is around £150 million annually.

Wales has the expertise to provide a solution and the capability to become a worldrecognised wound care and healing location.

It is home to a variety of research excellence in wound care, with Professor Keith Harding CBE and Professor Wen Jiang already acknowledged as global leaders in the field.

Wales also has a strong network which links the business, clinical and academic communities.

We have world-class research facilities at Swansea and Cardiff Universities combined with on-site hospital trialling facilities and experienced management and research teams.

Within the life sciences industry, ConvaTec has its global research and development for wound care products in North Wales. Fifty per cent of all ConvaTec’s global products are developed and manufactured in Wales and exported to 120 countries around the world.

7

SPRING 2013 BIOWALES BROCHURE

Welsh Government Overseas Events Programme 2013/2014 In 2013/14, the Welsh Government is offering an extensive programme of subsidised international trade activities in diverse markets to Life Sciences businesses based in Wales.

In addition, we will work with you to support standalone events which will increase export opportunities and grow your business.

Support is only available to companies based in Wales. For more information contact business@Wales.gsi.gov.uk or 03000 6 03000, and ask for the Life Sciences Sector team.

Event Name

Dates

Location

Sector

China International Medical Equipment Fair (CMEF)

17 -20 April

Shenzen, China

Life Science

Montreal (Canada) Trade Mission

21 – 26 April

Montreal, Canada

Multi-Sector (Trade Team)

Dubai (UAE) Trade Mission

May

Dubai, UAE

Multi-Sector (Trade Team)

E-Health

12 – 14 May

Dublin, Ireland

Life Science

Tokyo/Osaka (Japan) Trade Mission

6 - 16 June

Osaka/Tokyo, Japan

Multi-Sector (Trade Team)

Bio Israel

10 -12 June

Tel Aviv, Israel

Life Science

California Bio

11 -15 June

San Diego, USA

Life Science

Rio de Janeiro (Brazil) Trade Mission

25 – 28 June

Sao Paolo, Brazil

Multi-Sector (Trade Team)

German Trade Mission

1 – 5 August

Berlin, Germany

Multi-Sector (Trade Team)

Lorient

2 – 11 August

Lorient, France

Multi Sector

Medicon Valley (Visit 1 Denmark)

1 – 6 September

Copenhagen, Denmark

Life Science

AdvaMed

23 – 25 September

Washington DC, USA

Life Science

Mumbai (India) Trade Mission

13 – 18 October

Mumbai, India

Multi-Sector (Trade Team)

Doha (Qatar) Trade Mission

October

Doha, Qatar

Multi-Sector (Trade Team)

Shanghai (China) Trade Mission

3 – 8 November

Shanghai, China

Multi-Sector (Trade Team)

Medica

20 -23 November

Dusseldorf, Germany

Life Science

Arab Health

27 - 30 January

Dubai, UAE

Life Science

Istanbul (Turkey) Trade Mission

January

Istanbul, Turkey

Multi-Sector (Trade Team)

Medicon Valley (Visit 2 Sweden)

1 – 6 February

Malmo/Stockholm, Sweden

Life Science

Moscow (Russia) Trade Mission

February

Moscow, Russia

Multi-Sector (Trade Team)

Bio Europe

1 – 4 March

Munich, Germany

Life Science

Chongqing (China) Trade Mission

2 – 7 March

Chongqing, China

Multi-Sector (Trade Team)

2013

2014

West Coast (USA) Trade Mission March

8

West Coast (San Francisco Multi-Sector (Trade Team) or Seattle), USA

The Welsh Government Life Sciences Team – Taking Life Sciences Businesses to the World The Life Sciences Team can offer access to appropriate networks, employee development opportunities, NHS procurement advice, trade and export development, R&D, funding advice, and property opportunities for both existing Welsh businesses and potential inward investors.

The Life Sciences 2012/13 international trade programme was extremely successful, providing support for over 100 delegates representing over a fifth of all Welsh life science businesses. The events attended were CMEF (Chengdu), AdvaMed (Boston), Medica (Düsseldorf), and Arab Health (Dubai).

AdvaMed Boston

Medica Düsseldorf

Arab Health Dubai

CMEF Chengdu

Medica 2012 – Largest Ever Welsh Government Delegation A delegation of 70 people from 35 life science companies and organisations travelled to the Medica trade event in November 2012. This highlighted the drive to increase the international profile of the sector through increased trade and export activity.

For more information about the support programme for trade in 2013/14, speak to a member of the Welsh Government Life Sciences Team at BioWales 2013.

Why Wales?

We strive to create the right environment for business and we’ve been actively helping companies locate and prosper in Wales for decades. Here are just some of the reasons why you could succeed in Wales: £100 million Life Sciences Investment Fund – to support and develop the life sciences sector in Wales.

Strategic location – just two hours from London with rail, air and sea transportation links to all major UK and continental markets.

Specialist areas in life sciences – including medical technology, diagnostics, regenerative medicine, contract research organisations, and E-health.

Financial support and grants – the highest levels of grant funding offered in the UK with quick decisions and approvals.

An independent and devolved National Health Service (NHS) – committed to supporting innovative technologies and therapies to reduce costs and improve patient outcomes.

Quality and competitively-priced commercial and industrial property – some 40% lower than London rates.

Renowned university system – with research focused on industrial collaboration and more than 12,000 graduates across life sciences disciplines each year.

Massive broadband availability – with a commitment to roll out Next Generation Broadband across Wales by 2015.

Ready-built supply chains – support infrastructure in place to serve a growing cluster of life sciences companies.

To find out more about life sciences business in Wales, join us at Stand 16 or contact us: Tel: 03000 6 0 3000 Email: business@wales.gsi.gov.uk 9

SPRING 2013 BIOWALES BROCHURE

Gwyddorau Bywyd:

Llywodraeth Cymru’n Cefnogi Busnesau i Weddnewid Gofal Iechyd Byd-eang Eleni, rydym yn rhoi sylw i gwmnïau allweddol ym myd diwydiant sy’n darparu atebion gofal iechyd er mwyn datblygu’r agenda iechyd a chyfoeth, ac yn dangos pam mae Cymru’n wlad sy’n werth buddsoddi ynddi.

Cydweithio er mwyn Datblygu Atebion Gofal Iechyd y Dyfodol Mae llwyddiannau aruthrol Cymru yn 2012/13 yn cynnwys y canlynol: Agorodd GE Healthcare ei labordai

Buddsoddi ar gyfer Twf Mae Llywodraeth Cymru wedi cadw at ei gair o ddatblygu twf yn y sector yn 2012/13. Rydym wedi cynnig buddsoddiad gwerth dros £6.5 miliwn i ddetholiad amrywiol o fusnesau gwyddorau bywyd, o fusnesau bach a chanolig sydd â chynlluniau ehangu uchelgeisiol, i gwmnïau rhyngwladol sy’n gobeithio sicrhau eu presenoldeb yng Nghymru.

Byddwn yn adeiladu ar y momentwm hwn drwy gynnig buddsoddiadau pellach a thrwy gynyddu ein rhaglen masnach ryngwladol. Bydd rheolwyr Cronfa Gwyddorau Bywyd Cymru sy’n werth £100 miliwn yn buddsoddi hefyd er mwyn sicrhau bod gwyddorau bywyd yng Nghymru yn gallu cystadlu ar lefel ryngwladol.

10

Gwyddoniaeth Celloedd yn swyddogol yng Nghanolfan Maynard, Caerdydd ym mis Rhagfyr 2012. Mae’r Ganolfan yn gyfleuster allweddol ar gyfer ymchwil a datblygu GE Healthcare Life Sciences.

Sefydlwyd y labordai newydd yn dilyn buddsoddiad gwerth £3 miliwn gan fusnes GE Healthcare Life Sciences er mwyn creu canolfan ragoriaeth o’r radd flaenaf ym maes Gwyddorau Celloedd yng Nghymru.

Bu Haemair yn parhau i weithio gydag academyddion ym Mhrifysgol Abertawe er mwyn datblygu cymhorthion anadlu sy’n dynwared perfformiad ysgyfaint iach. Nod y prosiect yw datblygu prototeip o gymhorthion anadlu er mwyn gwella ansawdd bywyd cleifion ac fe’i ariennir gan raglen Arbenigedd Academaidd i Fusnesau Llywodraeth Cymru.

Wrth i BioCymru ddathlu ei benblwydd yn un ar ddeg, mae Llywodraeth Cymru’n cyhoeddi ei chamau nesaf ar gyfer cefnogi’r twf ym maes gwyddorau iechyd.

Dyfarnwyd grant o £250,000 i Q Chip gan Fwrdd Strategaeth Technoleg a gefnogir gan y Llywodraeth tuag at gostau datblygu proses weithgynhyrchu fferyllol flaengar ac arloesol sy’n sicrhau bod cyffur yn cael ei ryddhau’n araf a chyson. Mae Q Chip wedi datblygu dull newydd sbon o weithgynhyrchu mathau o gyffuriau sy’n cael eu rhyddhau’n araf fel hyn ar gyfer pigiadau o dan y croen.

Enillodd EKF Diagnostics y categori ar gyfer y ffordd orau o ddefnyddio’r Farchnad Fuddsoddi Amgen yng Ngwobrau’r Farchnad Fuddsoddi Amgen. Mae EKF Diagnostics yn arbenigo ym maes datblygu, cynhyrchu a dosbarthu dadansoddwyr lleol i gleifion ar gyfer darganfod a rheoli diabetes, anemia, clefyd lactad a chlefyd yr arennau.

Cafodd Biotec Services International ei enwi fel y busnes rhyngwladol gorau yn y DU yng Ngwobrau Siambr Siambrau Masnach Prydain. Mae’r cwmni o Ben-y-bont ar Ogwr yn cael ei gydnabod fel arweinydd byd-eang ym maes gwasanaethau fferyllol sy’n rheoli tymheredd.

6m

£

2.2m

Mae’r prif gyflogwyr yng Nghymru yn cynnwys:

£2.2f

£1f

£6f

Biomet UK GE Healthcare

Alere

£1.25f

Nice-Pak

Siemens

Norgine Penn Pharma

ConvaTec

Dyma’r Arian a Godwyd yn ddiweddar: Medaphor £1f Clinithink £1.25f Nanotether Discovery Services £2.2f Wockhardt £6f

Y Byd Academaidd a Diwydiant – Cydweithredu ar gyfer Twf Mae ein sefydliadau academaidd wedi parhau i ddarparu ymchwil o’r radd flaenaf ac maent wedi adeiladu ar gyfres o brosiectau sydd eisoes yn nodedig er mwyn tyfu’r sector yng Nghymru yn 2012/13:

Y Cyngor Ymchwil Feddygol yn Buddsoddi ym Mhrifysgol Abertawe Ym mis Awst 2012, cyhoeddodd y Cyngor Ymchwil Feddygol ei fod yn buddsoddi £19 miliwn er mwyn sefydlu pedair canolfan ragoriaeth ymchwil e-iechyd. Bydd Prifysgol Abertawe yn gartref i un o bedair canolfan ragoriaeth ym maes ymchwil e-iechyd yn y wlad, gyda thua £4.5 miliwn o’r cyfanswm yn cael ei fuddsoddi yng Nghanolfan Cyngor Ymchwil Feddygol gyntaf Prifysgol Abertawe.

Sefydliad Ymchwil Bôngelloedd Canser Ewropeaidd ym Mhrifysgol Caerdydd Mae tîm o Ysgol y Biowyddorau wedi nodi gwendid mewn bôn-gelloedd canser y fron, y math o gell sy’n gyfrifol am ymledu tiwmorau ac am ail byliau o salwch. Yn ôl Dr Richard

Clarkson sy’n arwain y tîm ymchwil ‘rydym ni’n credu ein bod ni wedi dod o hyd i fan gwan pwysig iawn ym môn-gelloedd canser y fron. Gallwn bron iawn eu hatal yn llwyr rhag ymledu’r clefyd drwy’r corff drwy diwmorau eilaidd’.

Gwyddorau Bywyd ym Mhrifysgol Abertawe Mae’r prosiect Gwyddorau Bywyd Cymru, a gefnogir gan raglen Arbenigedd Academaidd i Fusnesau Llywodraeth Cymru a ariennir gan Ewrop yn gydweithrediad arloesol rhwng y byd academaidd, y byd busnes a’r GIG yng Nghymru. Bydd y prosiect yn ystyried sut y gall gwyddorau bywyd wneud hyd yn oed mwy o gyfraniad at yr economi.

Bydd Gwyddorau Bywyd Cymru, a arweinir gan yr Athro David Ford, yn dwyn ynghyd Prifysgolion Abertawe a Chaerdydd â sefydliadau academaidd eraill, sector masnachol y gwyddorau bywyd a’r GIG er mwyn annog arloesedd, hyrwyddo’r gwaith o gydweithredu, nodi cyfleoedd a rhannu gwybodaeth a’r broses o ddatrys problemau yn y sector.

Sylw i: Gofal Clwyfau yng Nghymru Mae’r maes gofal clwyfau yn cyflogi tua 1600 o bobl yng Nghymru gyda throsiant masnachol o dros £70 miliwn yn flynyddol ac incwm ymchwil o dros £1.5 miliwn. Mae cyfanswm o £150 miliwn yn cael ei wario ar ofal clwyfau yn flynyddol yng Nghymru.

Mae gan Gymru’r arbenigedd i ddarparu atebion a’r gallu i fod yn lleoliad gofal a gwella clwyfau o’r radd flaenaf. Mae’n gartref i bob math o ragoriaeth ym maes ymchwil gofal clwyfau, ac mae’r Athro Keith Harding CBE a’r Athro Wen Jiang eisoes yn cael eu cydnabod fel arweinwyr byd-eang yn y maes. Mae gan Gymru hefyd rwydwaith cryf sy’n cysylltu’r cymunedau busnes, clinigol ac academaidd.

Mae gennym gyfleusterau o’r radd flaenaf ym mhrifysgolion Abertawe a Chaerdydd yn ogystal â chyfleusterau ar gyfer cynnal treialon mewn ysbytai a thimau rheoli ac ymchwil profiadol.

Yn y maes gwyddorau bywyd, mae ConvaTec wedi sefydlu ei waith ymchwil a datblygu byd-eang ar gyfer cynhyrchion gofal clwyfau yn y Gogledd. Mae pum deg y cant o holl gynhyrchion byd-eang ConvaTec yn cael eu datblygu a’u gweithgynhyrchu yng Nghymru a’u hallforio i 120 o wledydd ledled y byd.

11

SPRING 2013 BIOWALES BROCHURE

J&J

Architecture and Design for Science and Healthcare THiNK Research and Innovation Brief Writing. Feasibility Studies. Master Planning. Laboratory Planning. Healthcare Planning.

Architecture. Town Planning. Interior Design. Landscape Design. BREEAM/LEED. www.ibi-nightingale.com | www.ibigroup.com

Design for Life Brand-led design and marketing for Life Science organisations • Branding • Graphic design • Web and digital design • Technical web development • Packaging • Exhibiton material • Social media • Events • Publications

CONTACT US TO DISCUSS YOUR PROJECT 029 2047 3455 studio@teamworksdesign.com

7 Schooner Way, Atlantic Wharf, Cardiff, CF10 4DZ

www.teamworksdesign.com

Tîm Gwyddorau Iechyd Llywodraeth Cymru – Busnesau Gwyddorau Bywyd i’r Byd Gall y Tîm Gwyddorau Bywyd gynnig mynediad i rwydweithiau priodol, cyfleoedd datblygu ar gyfer gweithwyr cyflogedig, cyngor ar gaffael y GIG, datblygiadau masnach ac allforio, Ymchwil a Datblygu, cyngor ar gyllid, a chyfleoedd o ran eiddo ar gyfer busnesau sydd eisoes yn bodoli yng Nghymru a darpar fuddsoddwyr.

Roedd rhaglen fasnach ryngwladol Gwyddorau Bywyd 2012/13 yn hynod lwyddiannus, gan roi cymorth i dros 100 o’r rhai a fynychodd a oedd yn cynrychioli un o bob pump o holl fusnesau gwyddorau bywyd Cymru. Dyma’r digwyddiadau a fynychwyd: CMEF (Chengdu), AdvaMed (Boston), Medica (Düsseldorf), ac Arab Health (Dubai).

AdvaMed Boston

Medica Düsseldorf

Arab Health Dubai

CMEF Chengdu

Medica 2012 – Dirprwyaeth Fwyaf Erioed Llywodraeth Cymru Daeth dirprwyaeth o 70 o bobl o 35 o gwmnïau a sefydliadau gwyddorau bywyd i ddigwyddiad masnach Medica ym mis Tachwedd 2012. Roedd yn amlygu’r ymgyrch i gynyddu proffil rhyngwladol y sector drwy gynyddu gweithgarwch masnach ac allforio.

Pam Cymru?

Rydym yn ymdrechu i greu’r amgylchedd cywir ar gyfer busnesau, ac rydym wedi bod wrthi’n ddyfal yn helpu cwmnïau i sefydlu a ffynnu yng Nghymru am ddegawdau. Dyma rai o’r rhesymau pam y gallech chi lwyddo yng Nghymru: Cronfa Fuddsoddi Gwyddorau Bywyd gwerth £100 miliwn – i gefnogi a datblygu’r sector gwyddorau bywyd yng Nghymru.

Lleoliad Strategol – dim ond dwy awr o Lundain, gyda chysylltiadau rheilffordd,

Am ragor o wybodaeth am y rhaglen gymorth ar gyfer masnach yn 2013/14, siaradwch ag un o aelodau Tîm Gwyddorau Bywyd Llywodraeth Cymru yn nigwyddiad BioCymru 2013.

maes awyr a môr â’r holl brif farchnadoedd yn y DU ac ar y cyfandir.

a therapïau arloesol er mwyn lleihau costau a gwella canlyniadau cleifion.

Arbenigeddau mewn meysydd gwyddorau bywyd - gan gynnwys technoleg feddygol, diagnosteg, meddygaeth adfywiol , sefydliadau ymchwil dan gontract ac e-iechyd.

Prisiau cystadleuol i eiddo masnachol a diwydiannol o safon – tua 40% yn is na chyfraddau Llundain.

Cymorth ariannol a grantiau - y grantiau mwyaf a gynigir yn y DU ac mae’r broses o benderfynu a chymeradwyo yn un gyflym.

Gwasanaeth Iechyd Gwladol annibynnol a datganoledig – sydd wedi ymrwymo i gefnogi technolegau

System Prifysgol Adnabyddus gydag ymchwil yn canolbwyntio ar gydweithredu diwydiannol a thros 12,000 o raddedigion yn dilyn disgyblaethau gwyddorau bywyd bob blwyddyn Darpariaeth band eang ragorol – gydag ymrwymiad i gyflwyno Band Eang y Genhedlaeth Nesaf ledled Cymru erbyn 2015.

Am fwy o wybodaeth am wyddorau bywyd yng Nghymru, dewch i’n stondin neu ffoniwch 03000 6 0 3000 neu e-bostiwch: business@wales.gsi.gov.uk 13

SPRING 2013 BIOWALES BROCHURE

Contained Manufacturing Operations with a difference

Penn Pharma

Penn Pharma is uniquely positioned with the opening of a brand new purpose built facility offering a full high containment manufacturing service solution to the outsourcing market.

For more information contact +44 (0)1495 711222 or visit www.pennpharm.com

IP for the Life Sciences • Patents

• Trade Marks

Offices in Cardiff and Cheltenham Tel: +44 (0) 2920 786535 Email: email@wynne-jones.com Web: www.wynne-jones.com

Speaker Profiles Sue Heatherington Director - Waterside Consulting, Senior Associate Foresight Partnership Sue came to Wales in 2005 as Chief Executive of Swansea Local Health Board, having been foundingChief Executive of an early wave PCT in England. This unique experience of senior leadership in the NHS in both England and Wales serves her well in working with NHS, public and private sector organisations in both countries.

Sue established Waterside Consulting in 2009. Her current clients include research collaboratives, universities, life science companies, health and social care organisations, and a broad cross-section of SMEs. Sue’s work with public sector boards is with Foresight Partnership – a highly regarded, niche consultancy specialising in governance and board effectiveness.

She is a Fellow of the Royal Society of Medicine and a professional leadership coach.

Professor Sir Christopher Evans, OBE Founder & Chairman - Excalibur Fund Managers & Excalibur Group, Chairman - Arthurian Life Sciences Sir Christopher’s considerable contributions to the biotechnology industry were honoured with a Knighthood in the 2001 New Year’s Honours List. In 1987-1994 he created Cambridge’s first biomedical companies, starting the now famous Cambridge Cluster which has grown from Sir Chris’ earlier start-ups to some 350 companies worth over $7 billion. In 1996, Sir Chris founded Merlin Biosciences, which currently manages over $600 million of its own funds and is one of Europe’s foremost venture capital firms specialising in medical sciences. Sir Chris has established forty-five successful, high-quality science companies, twenty of which have been taken public on five stock markets.

Conor McKechnie Head of Communications & Public Affairs - GE Healthcare Life Sciences division Conor McKechnie has worked in communications and public affairs for global healthcare, science and technology companies for more than 15 years. He has an MA in Philosophy and Business at the Universities of Glasgow and California, Santa Barbara. Since then his career has focused on the promotion of cross-cultural and cross-discipline understanding and communication in science, technology and bio-ethics.

Conor is a passionate advocate for public and civic understanding of, and engagement in, science, medicine and bio-technology on the premise that better understanding means better, more effective evidencebased decision-making and leads to better health and health-economic outcomes.

Prof. Andrew R. Barron Charles W. Duncan, Jr. - Welch Chair of Chemistry and Professor of Materials Science – Rice University, Houston, Texas After gaining his BSc and PhD degrees from Imperial College London and performing postdoctoral research at the University of Texas, Barron spent eight years as a Professor of Chemistry at Harvard University before moving to Rice University in 1995. He is an Honorary Chair of Nanotechnology at Swansea University. Prof.

Barron is a Fellow of the Royal Society of Chemistry and the recipient of several national and international awards.

His research, core to a number of Rice startup companies, is focused on the application of nanotechnology to fundamental problems in energy and health research, with projects involving downhole sensors, carbon dioxide mitigation, and cancer treatment.

Brenig Preest Investment Director – Excalibur Brenig is an experienced Investment Director at Excalibur in London and Cardiff, specialising in life science investments. For over 10 years Brenig has invested in a wide range of successful growth and venture businesses. Prior to this, he worked at GE Healthcare before becoming a corporate finance advisor. As an investor and advisor Brenig has been involved in £0.5bn of transactions. Brenig studied Pharmacology at Cardiff University and Financial Strategy at Oxford University. He is also a qualified chartered accountant.

Dr Allan Syms UKTI Sector Champion – Life Sciences Champion (USA and China) Allan Syms has over 25 years’ experience in business development and technology venturing through creating, funding and building high technology healthcare businesses internationally. He has held senior marketing positions, spending significant time in South East Asia, USA and Europe. Allan has been CEO and remains a Director of a number of high technology start-up businesses. Currently he is Director of Licentia, myPinPad (IT security), and SecureBio (security for bio-threats), and runs a consultancy business advising clients on international business development and financing. Allan has a PhD in Cancer Research and completed postdoctoral research at Baylor College of Medicine in Houston, Texas and Oxford University.

15

SPRING 2013 BIOWALES BROCHURE

Anne Avidon Vice Consul, Trade and Investment Officer UK Trade & Investment

Dr Martin Murphy Clinical Director & Architect NHS Wales Informatics Service

Anne Avidon guides UK businesses in commercialising their medical devices and technologies in the US market. She also works with US firms to help them understand the strengths of Britain’s healthcare and life sciences sector in order to promote crossborder collaboration and inward investment into the UK. Anne has a Masters Degree from the University of Westminster, and is an active member of the Massachusetts Medical Device Industry Association (MassMEDIC), the Medical Development Group (MDG), the New England Health Information Management Systems Society (NEHIMSS) and the Massachusetts Technology Leadership Council (MTLC).

In addition to his role at NHS Wales Informatics Service, Dr Martin Murphy is the Caldicott Guardian for NHS Wales and a practicing GP. Dr Murphy studied medicine at the universities of Cambridge, Wales and Manchester and had a 13-year medical career before moving to management. Dr Murphy was director of IM&T across a hospital trust and two primary care trusts, a director of the NHS Information Authority, and joined the Informing Healthcare programme in 2005 as Clinical Director.

He now chairs the National Architecture Board and is responsible for the governance processes required to deliver the information services supporting the transformation of care in Wales.

Jon Sussex Deputy Director - Office of Health Economics, London

Professor David Ford Professor of Health Informatics - Swansea University

Jon Sussex is Deputy Director of the Office of Health Economics, London; an independent producer of health economics and policy research; and provider of economic and policy consultancy to the pharmaceutical and health care sector. He is an economist with over 25 years’ experience researching and advising on health sector and medical research policy and its implementation. His current research projects include measurement of time lags in medical research from early thinking to widespread use, and a survey of the extent of bioprocess development activity in the UK. Jon is an Honorary Visiting Fellow at the Centre for Health Economics at the University of York.

In addition to David’s role as Director of ehi2, he is also University Director of Health Informatics Research Laboratories, a collaboration between the College of Medicine, Swansea University and NHS Wales Informatics Service. The laboratories provide state-ofthe-art facilities to design, prototype, test and evaluate innovative new information technologies for use in improving health and healthcare. David is joint lead of the Health Information Research Unit for Wales; Deputy Director of a new UK Centre of Excellence for E-Health Research (E-HIRC); a Fellow of the Royal Society for the Encouragement of the Arts, Manufactures and Commerce (FRSA); and past Chairman and a current Director of MediWales.

Mirella Marlow Programme Director – Devices and Diagnostic Systems, Centre for Health Technology Evaluation, National Institute for Health and Clinical Excellence (NICE) Mirella Marlow joined NICE in 2004 as an Associate Director on the Technology Appraisals Programme, having previously worked for 15 years as a commissioner in the NHS. She went on to manage NICE’s Interventional Procedures Programme and established the Patient Safety Pilot Programme in collaboration with the NPSA. Mirella was involved in planning the new developments at NICE on the evaluation of devices and diagnostics. She has an MBA and a Masters in Medical Ethics and Law from Keele University, where her interests included the ethics of measuring the cost-effectiveness of interventions to improve the safety of healthcare, and legal cases relating to healthcare rationing.

16

Mark Smith UK Director - Microsoft Healthcare, Life Science & Consumer Healthcare Mark‘s direct team at Microsoft includes industry solutions, market development, technology strategists and account management, and he influences an extended team covering partner, services and marketing strategy. A critical part of Mark’s strategy is building, driving and publicising relevant solutions within Healthcare & Life Sciences.

Mark joined Microsoft in 2004 and has over 15 years’ experience in software solutions. Prior to his current role, Mark was Public Sector Director for the Small and Mid-sized Solution & Partner Business for 4 years, responsible for Microsoft’s business in Education, Healthcare, Blue Light, Central & Local Government as well as the partner engagement strategy across all Public Sector SMEs.

Craig Story Managing Director - Kodit Database

WEDS 20th MARCH

In 1992, Craig co-founded Kodit Database with a mission to provide accurate traceability of assets, initially in corporate IT environments. In 2005, realising the benefits mobile technology would bring to healthcare, Craig became involved in evaluating healthcare platforms and their capabilities. Working with subject matter experts, Craig led the technical team that developed the CAREMagic platform; technology now being utilised to deliver Electronic Point of Care in areas such as diabetes, end of life, NEWS, SEPSIS, 1000 Lives and care home areas. Craig is currently working with GS1 and other regulatory bodies on developing the UDI solution for medical device manufacturers across EMEA.

Lesley Griffiths AM Minister for Health and Social Services

Dr Chris Tackaberry CEO & Co-Founder - Clinithink Dr Chris Tackaberry is CEO and Co-Founder of Clinithink, a healthcare technology company that operates out of Bridgend, London and Atlanta in the US. Chris left clinical practice and combined his medical expertise and MSc degree in Computer Science when he joined iSOFT, a UK-based healthcare software company operating globally. After leaving iSOFT, Chris built a successful consulting practice focused on technology strategy, product management and major systems implementation.

In 2009, Chris co-founded Clinithink and steered the business to success in the US. He continues to lead Clinithink in delivering world-class technology designed to benefit the healthcare industry in terms of coding, clinical decision-support and big data analytics.

Tom Frohlich Commercial Trial Leader Janssen Healthcare Innovation Tom currently works as a Commercial Trial Leader in Janssen Healthcare Innovation (JHI). JHI was established in 2010 by the Pharmaceutical Global Operating Committee with the vision to accelerate the transformation of J&J from a product-centric company to a broader health care company. JHI has the specific mission to identify, foster and manage a portfolio of transformational partnerships; accelerate the development, experimentation and learning from new ideas and business models that will lead to new revenue streams; as well as drive collaboration within J&J and the industry and enable the creation of new healthcare markets. Prior to JHI, Tom worked in Janssen’s European and Global Strategic market teams where he played a leading role in the launches of Stelara and Incivo.

Lesley worked at the Wrexham Maelor Hospital for twenty years, and prior to her election worked as constituency assistant to Ian Lucas, MP. As a strong supporter of devolution for Wales, she played an active role in the 1997 ‘Yes for Wales’ campaign. She was elected to the National Assembly for Wales in May 2007 and has sat on the Communities and Culture, Sustainability, and Audit Committees, and set up and chaired the Cross Party Hospice Group.

In December 2009, she was appointed Deputy Minister for Science, Innovation and Skills. Following re-election to the National Assembly for Wales in May 2011, Lesley Griffiths was appointed Minister for Health and Social Services.

David Sissling Director General Health, Social Services and Children/Chief Executive - NHS Wales David Sissling’s early career was spent in the private sector. He joined the NHS in 1993, becoming Chief Executive of The Leicester Royal Infirmary NHS Trust in 1998. David was subsequently Chief Executive of Northamptonshire Health Authority, the Leicestershire, Northamptonshire and Rutland Strategic Health Authority, and the Northern Ireland Health and Social Care Authority. He joined the Healthcare for London team in February 2008 to lead an ambitious programme of service change across the capital. He was appointed Chief Executive of ABM University Health Board in 2009, then in 2011 David was appointed as Director General, Health, Social Services and Children/Chief Executive, NHS Wales.

Professor Jonathan Bisson Clinical Director – National Institute for Social Care and Health Research (NISCHR) Academic Health Science Collaboration (AHSC) In addition to Prof. Bisson’s role as Clinical Director of NISCHR AHSC, he is a Director of Research and Development for Cardiff University School of Medicine and Cardiff and Vale University Health Board. Jonathan originally worked as consultant psychiatrist and developed an interest in traumatic stress during his time in the British Army. He has conducted various studies including two widely cited trials of early psychological interventions following traumatic events, and three Cochrane systematic reviews in the traumatic stress field.

He was co-chair of the UK’s PTSD NICE Guideline Development Group and is Director of the all Wales Veterans’ Health and Wellbeing Service.

17

SPRING 2013 BIOWALES BROCHURE

Professor Keith Harding, CBE Head of Wound Healing Research Unit, Director of TIME Institute (Translation, Innovation, Methodology and Engagement) - School of Medicine, Cardiff University.

Professor Keith Harding has had a longstanding interest in wound healing. He is currently Director of TIME Institute (Translation, Innovation, Methodology and Engagement); Head of Wound Healing Research Unit, Cardiff University; and Clinical Lead for Wound Healing in the Cardiff & Vale NHS Trust.

An expert in wound healing, Prof. Harding has authored over 300 publications in the field. He is currently Editor-in-Chief of the International Wound Journal and has chaired numerous prestigious panels and societies in the past. He has obtained extensive funding from a range of academic, commercial and clinical sources since the Wound Healing Research Unit was created in 1991. Prof. Harding was awarded the CBE in the New Year’s Honours list in January 2013.

Dr Andrew Goodall Chief Executive - Aneurin Bevan Health Board Dr Andrew Goodall is Chief Executive of the Aneurin Bevan Health Board. He has been a Chief Executive in NHS Wales since 2005 and has also held planning and operational positions with organisations across South Wales over the last 22 years. Dr Goodall has a Law degree from Essex University and a PhD in Health Service Management from Cardiff Business School. His interests involve improving patient safety and the patient experience; partnership working across Public Services; and delivering frontline services through service improvement and modernisation. Dr Goodall has also chaired the Effective Services for Vulnerable Groups work stream for the Welsh Government.

Tony Halsall Associate Director – NHS Confederation Tony Halsall has been an Associate Director at the NHS Confederation since April 2012. Tony was responsible for establishing the NHS Confederation Hospitals Forum, where the NHS comes together to discuss issues that affect and impact on hospital service providers. Tony has also worked with the Northern Ireland Health and Social Care Confederation to strengthen links between the two Confederations. Tony has 9 years’ experience as an Acute Trust Chief Executive and has also held Executive Director roles in nursing and operations at a number of hospitals across the North West of England.

18

Paul Johnson Managing Director - Outsourcing Consultants Paul Johnson graduated from Cardiff School of Physiotherapy and following this, served in the Royal Navy Medical Services for six years. He finished his military career as head physiotherapist at the Commando Training Centre Royal Marines.

In 1998 Paul moved to work in a hospital in Dubai and helped it to achieve JCI accreditation. Here Paul gained valuable insight that sparked the idea for Outsourcing Consultants. Formed 12 years ago, Outsourcing Consultants set out with the aim of focusing on recruitment, human resources and consultancy within the healthcare sector in the Arabian Peninsula.

Paul has assisted companies both privately and through the Welsh Government for many years, linking closely with the regional representative based in Dubai covering the MENA region.

Alina Niebla Trade and Investment Officer – UK Trade & Investment Havana Alina Niebla works as Trade and Investment Officer in Havana, leading on biotechnology, healthcare, pharmacy and energy sectors, which are priority sectors in Cuba. She has been working in this market for UKTI for 5 years.

Her main roles are to introduce British companies to the Cuban market and to provide support to facilitate the success of new businesses. Among other tasks, Alina also provides effective support to the British Group in Cuba throughout the financial year, and promotes and supports trade development activities in life sciences and energy.

Dr Graham Bell Lead Specialist, Stratified Medicine Innovation Platform - Technology Strategy Board Dr Bell joined the Technology Strategy Board in 2010 as the lead specialist in the Stratified Medicine Innovation Platform. Graham has over 20 years’ experience working in SME in UK in drug development, business and corporate development roles. With a background in both operating and business/corporate development roles, he has experience of building and managing research groups from the ground up. Graham has coordinated large, multifunctional groups in due diligence exercises for both technical and legal due diligence.

Professor Ursula Hultkvist Bengtsson Associate Professor in Bio Pharmaceutics Uppsala University, Sweden

Dr Martin James Global R&D Leader, Bio-Research Tools GE Healthcare, Life Sciences.

Ursula Hultkvist Bengtsson joined Medicon Village in Lund, Sweden, a life science village for research, innovation and business, from its launch in early 2012.

As Executive Vice President, Ursula leads strategic development - including the internationalisation of Medicon Village. Ursula joined AstraZeneca in 1995 and held a number of different roles with the organisation.

Prior to this, Ursula did her post-doc at Sandoz in Switzerland and earned her PhD in Animal Physiology in 1988, Lund University, Sweden.

Martin studied for his BSc and PhD in organic chemistry at the University College of Swansea before working as a post-doctoral research fellow in marine natural product chemistry at the Scripps Institute of Oceanography at La Jolla San Diego. He joined GE Healthcare in 1990, holding roles in supply chain, technical support and R&D. In 2008 Martin was appointed integration leader for the GE acquisition of Whatman, then moved on to a business development and strategy role working on global projects for the diagnostic imaging and life science supply chain organisation at GE Healthcare. In 2011 Martin was appointed to his current role managing global R&D sites and projects.

Anna Chérouvrier Hansson Head of Business Development Life Science Invest in Skåne Anna Chérouvrier Hansson heads the Life Science Business Unit at Invest in Skåne, the official regional promotion agency facilitating inward investment to Skåne, Sweden. Anna is responsible for the overall strategy for the international business development activities in the life science business unit. Hansson and her team have been involved in more than 20 investments over the past three years. She holds a double-bachelor degree in Business Administration as well as a Master of European Affairs in Business Administration and Business Law. Dr Grahame Guilford Life Science Panel Member - Welsh Government Dr Guilford worked in the life science sector for 30 years with Amersham International, now GE Healthcare. He now runs a small consultancy working with universities and small companies on the commercialisation of their expertise. He has been closely involved in economic development for 15 years through the Welsh Development Agency and the Welsh Government. He is a member of the South East Wales Economic Forum and also a member of the Welsh Government Advisory Panel on the Life Sciences sector and the Governing Council of Cardiff University.

Matthew West Plant Manager, Ortho Clinical Diagnostics UK Operations Matthew West is the Plant Manager for Ortho Clinical Diagnostics UK Operations based near Bridgend.

The site supplies immunoassay products used for the diagnosis of a range of diseases to customers around the world. Although the history of manufacture of immunodiagnostics by the company in South Wales extends to over 20 years, Matthew led the project to build and transfer operations to a purpose built site in Pencoed, which opened in 2009. Matthew is a Chartered Chemical Engineer with over 20 years’ experience in the healthcare manufacturing industry covering pharmaceuticals, sterile products and medical devices.

John Roberts Commercial Director - Penn Pharma John Roberts has 30 years’ experience in the international pharmaceutical industry, encompassing general management, marketing, business development, manufacturing and clinical development.

His early career was spent with Wellcome PLC in the UK, Singapore and Thailand, followed by 10 years with UCB Pharma SA where he was Regional Director Asia and then UK & Ireland Managing Director. In 2005 he returned to Wales and joined Penn Pharma, a leading provider of pharmaceutical product development and manufacturing service.

Robyn Wood Vice President, Data & Programming Services - PRA Robyn Wood has worked in the pharmaceutical industry for nearly 19 years since leaving university in 1994 with a degree in Applied Chemistry. Robyn spent his early years at AstraZeneca before moving to the project management of clinical supplies. In 2004 Robyn moved into clinical trial management with ClinPhone and spent 8 years here before moving to his current position with PRA, where he leads the global teams of Clinical Systems Development, Clinical Data Coordination, Clinical Programming, External Support and Standards & Libraries.

Ifan Evans Deputy Director, Life Sciences and Regional Engagement - Wales Advisory Board Ifan joined the Welsh Government in 2011. He leads policy development and delivery in support of Life Sciences businesses throughout Wales, leads regional engagement with business and key stakeholders in South West and Mid Wales, and heads the Welsh Government’s office in Penllergaer, Swansea.

19

BioWales 2013 Programme Unrivalled Connectivity - Delivering Tomorrow’s Health Solutions Day 1 – Tuesday 19th March 2013 Master of Ceremonies: - Sue Heatherington, Director, Waterside Consulting & Senior Associate, Foresight Partnership Registration, Exhibition, Coffee and Networking

8:00

Delivering Tomorrow’s Health Solutions

9:30

Professor Sir Christopher Evans, OBE, Founder & Chairman, Excalibur Fund Managers & Excalibur Group and Chairman, Arthurian Life Sciences

10:10

Conor McKechnie, Head of Communication and Public Affairs, GE Healthcare “Keynote address”

10:40 – 11:00

Coffee Break

11:00

Professor Andrew Barron, Professor of Materials Science, Rice University “Turning innovation into a commercial reality”

11:30

Workshop pitches:“Doing business in Wales” – Brenig Preest, Investment Director, Excalibur “Doing business in China” – Allan Syms, UKTI Sector Champion “Healthcare market access in the United States”– Anne Avidon, Vice Consul, Trade & Investment Officer, UKTI

11:45 - 14:00

Lunch, Brokerage Meetings, Workshops & Exhibition

11:50 - 12:20 12:00 - 12:30 12:25 - 13:05

WORKSHOPS “Doing business in Wales” – Brenig Preest, Excalibur. Victor Salvi Room “Doing business in China” – Allan Syms, UKTI. Selligman Room “Healthcare market access in the United States”– Anne Avidon, UKTI. Victor Salvi Room

Technological Innovation – New Solutions For The NHS

14:00

Jon Sussex, Deputy Director, Office of Health Economics “Economic and health care benefits of public, charity and private life science research”

14:25

Mirella Marlow, Programme Director, Devices and Diagnostic Systems, Centre for Health Technology Evaluation, NICE “Facilitating new product development route to market within the UK”

14:50

Question & Answers

15:00 – 15:20

Coffee Break

Technological Innovation – New Solutions For The NHS (continued)

15:20

Dr Martin Murphy, Clinical Director NHS Wales “NHS Wales Informatics Service, overview, progress update and engagement with industry”

15:45

Professor David Ford, Professor of Health Informatics, Swansea University “Research opportunities for industry through the health informatics research laboratories”

16:00

E-Health Showcase Facilitator: Professor David Ford Current activities and future opportunities update

Mark Smith, Director, Healthcare, Life Sciences and Health Solutions Group at Microsoft

Craig Story, Managing Director, Kodit Database

Dr Chris Tackaberry, CEO, Clinithink

Tom Frohlich, Commercial Trial Leader, Janssen Healthcare Innovation

Question & Answers – E-Health Showcase panel

17:00

Close

17:00 - 18:00

Exhibition and Brokerage Meetings

18:30

Drinks Reception

19:30

Gala Dinner and Entertainment

22:30

Close

Day 2 – Wednesday 20th March 2013 Master of Ceremonies: - Sue Heatherington, Director, Waterside Consulting & Senior Associate, Foresight Partnership 8:00 - 9:00

Registration, Exhibition, Coffee and Networking

NHS Open To Commercialisation

9:00

Lesley Griffiths AM, Minister for Health and Social Services

9:10

David Sissling, Director General for Health Social Services and Children/Chief Executive, NHS Wales

9:25

Professor Jonathan Bisson, Clinical Director, National Institute for Social Care and Health Research, Academic Health Science Collaboration (NISCHR AHSC)

9:45

Professor Keith Harding CBE & company, Head of Wound Healing Research Unit, Director of TIME Institute, School of Medicine, Cardiff University.

10:20 – 10:40

Coffee Break

10:40

Dr Andrew Goodall, Chief Executive, Aneurin Bevan Health Board “Improving patient outcomes & patient experience through industrial innovation”

11:10

Tony Halsall, Associate Director, NHS Confederation

11:40

Question & Answers

11:45

Workshop pitches:“Opportunities and considerations for life science businesses in the Arabian Peninsula” – Paul Johnson, MD, Outsourcing Consulting “Doing business in Cuba” - Alina Niebla, Trade and Investment Officer, UKTI & Jorge Martín, Deputy Director, Business Development Group, Center for Genetic Engineering and Biotechnology “Technology Strategy Board company showcase: lg Innovations” - Dr Graham Bell, Lead Specialist, TSB.

12:00 - 14:15

Lunch, Brokerage Meetings, Workshops & Exhibition

12:05 - 12:35 12:15 - 12:45 12:40 - 13:10

WORKSHOPS “Opportunities and considerations for life science businesses in the Arabian Peninsula” – Paul Johnson. Selligman Room “Doing business in Cuba” - Alina Niebla, UKTI & Jorge Martín, Center for Genetic Engineering and Biotechnology. Sony Salvi Room “Technology Strategy Board company showcase: Ig Innovations” - Dr Graham Bell, TSB. Selligman Room

World Class Life Sciences

14:15

Ursula Hultkvist Bengtsson, Uppsala University and Anna Cherouvrier-Hansson, Invest in Skåne “Nurturing & flourishing life science businesses in Sweden”

14:40 - 15:50 Global Business Showcase Facilitator: Dr Grahame Guilford, Life Science Panel Member, Welsh Government “How it works for us” Mathew West, Plant Manager, Ortho Clinical Diagnostic (OCD)

Dr Martin James, Global R&D Leader, GE Healthcare

John Roberts, Commercial Director, Penn Pharmaceutical

Robyn Wood, Vice President, Data & Programming Services, Pharm Research Associates (PRA UK)

Questions and Answers

15:50 - 16:00

Closing address Ifan Evans, Head of Life Sciences, Welsh Government

16:00 Close

Exhibition plan and venue layout

37

JOHNSON AND JOHNSON CAFE

29 28 27 26

24

20

16

12

8

4

23

19

15

11

7

3

22

18

14

10

6

2

21

17

13

9

5

1

MAIN ENTRANCE

EXHIBITION AREA

25 30

31

32

33

34

35

CATERING AREA

36

STAGE

1

Beacon - Silver Sponsor

19 Insteng Process Automation

2

GX Group

20 IBI Nightingale - Delegate Bag Sponsor

3

PRA International

21 Cardiff University (ECSCRI and NMHRI)

4

Penn Pharma - Lanyard Sponsor

22 SymlConnect & MiTAC Europe

5

Swansea University - Centre for Nanohealth (CNH)

23 JANET

6

Cogent SSC

7

PleaseTech

24 PDR-The National Centre for Product Design + Development Research

8

Biotec Services International

9

Institute of Life Science

10 VolitionRx 11 Simbec Research 12 Health Research Wales (NISCHR) - Gold Sponsor 13 UCLB 14 Wales Cancer Bank (Cardiff Uni) 15 AbD Serotec

25 Esco GB 26 ASTUTE 27 Cardiff Medicentre 28 HPC Wales 29 Sharp Clinical Services 30 NHS Wales Informatics Service 31 Welsh Government Innovation Team 32 MediWales

16 Welsh Government Life Sciences Sector Team

33 PEMF Systems, Inc.

17 Institute of Translation, Innovation, Methodology and Engagement (TIME) in the School of Medicine (Cardiff University)

34 Ensinger Precision Engineering 35 BBSRC

18 Welsh Government Business Wales

37 Cafe sponsor - Johnson and Johnson

36 LabioFam SA

BioWales Wa l e s , L i fe S c i e n ce a n d t h e Wo r l d

Workshops Day 1 11.50 “Doing business in Wales” - Victor Salvi Room 12.00 “Doing business in China” - Selligman Room 12.25 “Healthcare market access in the United States” - Victor Salvi Room Workshops Day 2 12.05 “Opportunities and considerations for life sciences businesses in the Arabian Peninsula” - Selligman Room 12.15 “Doing business in Cuba” - Sony Salvi Room 12.40 “Technology Strategy Board company showcase: Ig Innovations“ - Selligman Room

SPRING 2013 BIOWALES BROCHURE

Confronting and mitigating climate change is a world-wide challenge.

One way of tackling this is to make products from renewable feedstocks such as ryegrass, oats and miscanthus rather than oil. is a ÂŁ20M Welsh Biorefining initiative supported by the EU and tasked to innovate with businesses to develop low carbon solutions.

Contact: e: beaconwales@aber.ac.uk t: +44 (0)1970 823041

http://www.beaconwales.org/ 24

Exhibitor Profiles Welsh Government - Life Sciences Sector Team Llys-Y-Ddraig Penllergaer Business Park Swansea SA4 9NX Tel: +44 (0)3000 603 000 Email: business@wales.gsi.gov.uk Web: www.business.wales.gov.uk

The Welsh Government is a democratically elected body. It has devolved powers and is responsible for developing and delivering policies in Wales covering many aspects of life including economic development, education, skills, and technology and innovation. Life science is a priority sector and a dedicated team is in place to support the growth and business development of this sector in Wales. Activities include trade, skills development, property needs, routes to market and Foreign Direct Investment (FDI).

Welsh Government – Innovation Team Main Avenue Treforest Industrial Estate Treforest Pontypridd Rhondda Cynon Taf CF37 5YR Tel: +44 (0)300 061 6042 Email: stella.asprou@wales.gsi.gov.uk Web: www.business.wales.gov.uk

We are part of the Welsh Government’s department for Business, Enterprise, Technology and Science (BETS). Our support is aimed specifically at technology-based businesses in Wales in nine key sectors including life sciences. We provide an integrated package of funding and support for all aspects of your business, from helping you develop new products and manage intellectual property assets, through design issues and manufacturing, to full commercialisation of your new products, services, processes and technologies. Our support is available at every step of the innovation process.

Attending: Jennifer Clark Innovation Promotions Manager Stella Llewellyn Stakeholder Engagement Executive

Welsh Government – Business Wales Sarn Mynach Llandudno Junction Conwy LL31 9RZ Tel: +44 (0)3000 060 000 Email: sharon.roberts2@wales.gsi.gov.uk Web: www.business.wales.gov.uk

Business Wales: A new service to drive your business forward. Tailored information, advice and support. Now all in one place. Supporting businesses in Wales.

Busnes Cymru: Gwasanaeth newydd i yrru eich busnes yn ei flaen.

Gwybodaeth wedi ei theilwra, cyngor a chefnogaeth. Y cyfan gyda’i gilydd. Yn cefnogi busnesau Cymru.

Attending: Kayleigh Gentile and Ros Duggan (attending on 19/03) Katherine Wood and Vicky Daley (attending on 20/03)

25

SPRING 2013 BIOWALES BROCHURE

AbD Serotec Langford Lane Kidlington Oxfordshire OX5 1GE Tel: +44 (0)1865 852700 Email: sales@abdserotec.com Web: www.abdserotec.com Attending: Hayley Clark Commercial Services Consultant Chris Bullion Commercial Services Consultant

AbD Serotec offers more than 14,000 antibodies and immunological reagents.

Our range serves a variety of areas including cell biology, immunology, and veterinary sciences. We also offer specialist anti-idiotypic antibodies for biotherapeutic drug monitoring, with uses in clinical drug development. Many antibodies are available in bulk quantities for use in diagnostic applications.

Additionally, AbD Serotec provides custom services including antibody production, conjugation, and purification. As well as traditional methods, AbD Serotec uses proven HuCAL® recombinant technology to generate custom monoclonal antibodies, resulting in fully human, high affinity Fab antibodies in just eight weeks without the immunisation of animals.

ASTUTE - Advanced SusTainable manUfacturing Technologies

Attending: Miss Beth Rendle Communications Officer Miss Rebecca Nelson Administrator

Room 109, Digital Technium College of Engineering Swansea University Swansea SA2 8PP Tel: +44 (0)1792 606837 Email: info@astutewales.com Web: www.astutewales.com

The £27 million ‘Advanced SusTainable manUfacturing TEchnologies’ project - part-funded by the ERDF through Welsh Government - has already collaborated with over 200 Welsh enterprises in the convergence area, helping them towards long-term sustainability and competitiveness through the implementation of advanced technologies and improved business processes.

To date, over 150 new or improved products, processes and services have been launched and 5 new enterprises ‘spun out’ as a direct result of the ASTUTE-led collaborations. ASTUTE has also succeeded in encouraging companies to adopt better environmental and equality practices, and embrace more waste-efficient, lean manufacturing processes.

BBSRC - Biotechnology and Biological Science Research Council

Attending: Dr Andrew Staphnill Business Interface Manager Mr Ben Sykes Senior Business Interaction Manager

Polaris House North Star Avenue Swindon Wiltshire SN2 1UH Tel: +44 (0)1793 413200 Email: webmaster@bbsrc.ac.uk Web: www.bbsrc.ac.uk

The Biotechnology and Biological Science Research Council (BBSRC) is one of seven research councils that form Research Councils UK (RCUK), and invests in world-class bioscience research and training on behalf of the UK public.

BBSRC had a budget of around £445M in 2011-12 and supports around 1600 scientists and 2000 research students in universities and institutes across the UK. BBSRC science contributes to overcoming challenges in areas such as food security, bioenergy and industrial biotechnology, and basic bioscience underpinning health. These areas are at the core of BBSRC’s remit and have been identified as key strategic research priorities.

BEACON Institute of Biological, Environmental & Rural Sciences (IBERS)

Attending: Dr Steven Fish Deputy Director Dr Mike Morris Business Development Manager

26

Aberystwyth University Gogerddan Aberystwyth Ceredigion SY23 3EB Phone: +44 (0)1970 823041 Email: beaconwales@aber.ac.uk Web: www.beaconwales.org

BEACON employs state-of-the-art biorefining and industrial biotechnology (IB), assisting companies in developing low carbon systems and ways of making products traditionally made from oil. BEACON aims to make a vital contribution to tackling climate change and offers businesses interested in IB, biorefining, and process technology sectors access to research expertise and pilot scale facilities within Wales. We are establishing links between the business community and academia; developing new products and processes to support economic growth; creating highly skilled jobs in the area of green biotech; supporting inward investment; and promoting science excellence both within and from Wales.

Biotec Services International

Attending: Hannah James Marketing Manager Paul Viggers Business Development Manager

Biotec House, Central Park Western Avenue Bridgend Industrial Estate Bridgend CF31 3RT Tel: +44 (0)1656 750550 Email: enquiries@biotec-uk.com Web: www.biotec-uk.com

Biotec has the expertise and experience required to support your clinical trials from Phase I to IV and on to commercial supply. Our split-site facility supports multinational trials and the commercial launch of our clients’ products on a daily basis. Our services include: clinical supplies, QP and GMP consultancy, GMP temperature controlled storage, global logistics, advanced therapeutic medicinal products (ATMPS), and commercial services. Biotec also handles containment level I and II genetically modified organisms (GMOs), Schedule II to V controlled drugs, and storage arrangements such as customs warehousing for a range of controlled temperatures from controlled ambient (15-25°C) down to -196°C.

Heath Park Cardiff CF14 4UJ Tel: +44 (0)29 2075 7744 Email: enquiries@cardiffmedicentre.co.uk Web: www.cardiffmedicentre.co.uk

Cardiff Medicentre is a dedicated medical, healthcare, life and bio science business incubator located on the Cardiff University Hospital of Wales Campus. It offers high quality office and laboratory accommodation and low cost desk leasing, comprising 32 units ranging from 284 sq ft to 1045 sq ft. Cardiff Medicentre offers specialist business incubation programmes and works closely with Welsh Government’s Life Science Sector Team and Cardiff Council’s Economic Development Unit to ensure Tenants have access to business support services. Cardiff Medicentre is a Joint Venture between Cardiff Council, Welsh Government, Cardiff & Vale University Health Board and Cardiff University.

Cardiff Medicentre

Attending: Mrs Jan Coward Centre Administrator Mr Robert Jackson Innovation Manager

Cardiff University School of Biosciences Sir Martin Evans Building Cardiff University Museum Avenue Cardiff South Glamorgan CF10 3AX Tel: +44 (0)2920 874829 Email: biosischooloffice@cf.ac.uk Web: www.cf.ac.uk

Cardiff University, founded by Royal Charter in 1883, is recognised in independent government assessments as one of Britain’s leading universities.

We combine impressive modern facilities and a dynamic approach to teaching and research; as a member of the Russell Group we are one of the UK’s most research-intensive universities. Our interdisciplinary themes facilitate research and teaching excellence, presenting unparalleled opportunities and challenges for science and its exploitation to benefit health and the environment. The Cardiff School of Biosciences, University Research Institutes, and National Centre for Mental Health will be exhibiting at BioWales 2013.

Unit 5 Mandarin Court Centre Park Warrington WA1 1GG Tel: +44 (0)1925 515220 Email: info@cogent-ssc.com Web: www.cogent-ssc.com

Cogent’s employer-led Life Sciences Skills plan is organised around four actions: 1. We will ensure that information on skills for the bioeconomy is up-todate, and use the evidence to drive communication between employers and universities/colleges to seek skills solutions.

2. A number of recommendations on specialist skills at risk were developed through the Department for Business Innovation and Skills’ (BIS) Life Sciences Blueprint. We will establish new solutions, owned by the sector itself.

3. We will develop a package of apprenticeships to support the existing workforce and develop a sustainable future supply of homegrown talent.

4. We will seek a brokerage solution to facilitate graduate placements to strengthen the science base across the sector.

Attending: Emma Dalton Facilities and Communications Officer Ian Horton Innovation and Partnership Office

Cogent SSC

Attending: Mr Andrew Evans Wales Manager Miss Helen Murray Product & Services Manager, Life Sciences

27

SPRING 2013 BIOWALES BROCHURE

Ensinger Precision Engineering

Attending: Mr Chris Vince Technical and Applications Manager Mr Mark Tipton Sales Manager

Wilfried Way Tonyrefail Mid Glamorgan CF39 8JQ Tel: +44 (0)1443 678500 Email: medical@ensinger.co.uk Web: www.ensinger.co.uk

Ensinger Precision Engineering is an ISO 13485 approved company and a market leader in the machining of precision engineered plastic components for the medical and life science industries. On the manufacturing side, 2, 3, 4 and 5-axis CNC turning, milling and routing capacity is available as well as solutions for finishing, polishing, part marking, ultrasonic cleaning and packaging, and assembly/kitting. The company is highly focussed on application engineering and works closely with customers on a technical level to assist in developing applications, specifying materials from the extensive Ensinger portfolio, and optimising parts for manufacture.

Unit 20 Parkers Close Downton Industrial Estate Downton Wiltshire SP5 3RB Tel: +44 (0) 1725 514555 Email: info@escogb.com Web: www.escogb.com

Esco GB supplies a wide range of laboratory equipment, from small scale installations to large scale projects across the UK and Ireland. Our support team of applications, installation and engineering experts allow us to provide top class service to all our customers. The Esco GB product range includes: microbiological safety cabinets (class I, II, and III); laminar flow cabinets (horizontal and vertical flow); ducted fume cupboards; ductless/recirculating fume cupboards; cleanroom equipment; CO2 incubators; laboratory ovens and incubators; and ultra low temperature freezers. We’ve built our reputation on user-friendly and reliable product design, and products which are competitively priced and energy efficient to save our customers money.

Our UK stock range includes many of our most popular models. These are available straight from our warehouse, enabling us to deliver selected models within a week of order receipt.

The Mayfield Usk Monmouthshire NP15 1SY Phone: +44 (0)1291 673 437 Email: claire.banks@gxgroup.com Web: www.gxgroup.com

GX Design Engineers are leaders in the field of diagnostic, medical, scientific instrumentation, and devices design and development. Our award-winning expertise has made us a forerunner in design engineering in the UK. We take your ideas and turn them into commercially viable products that meet the demanding technical and user requirements of your market. To achieve this we employ a wealth of experience, full understanding of all emerging technologies, problem-solving intelligence, and seamless project management. Our offerings include electronic hardware, software and user interface design; industrial and mechanical engineering; as well as specialist areas such as optronics and microfluidics.

Esco GB

Attending: Mr Gavin Barrett Managing Director Miss Laura Jones Operations Manager

GX Group

Attending: Mr Mark Helmich Managing Director Ms Claire Banks Business Development Manager

28

Health Research Wales

Health Research Wales

Phone: +44 (0)2920 230 457 Email: contact@healthresearchwales.com Web: www.healthresearchwales.com

Attending: Miss Helen Jones NISCHR AHSC Senior Manager Mrs Alex Hills NISCHR AHSC Manager

The Health Research Wales service has been established by the National Institute for Social Care and Health Research (NISCHR) Academic Health Science Collaboration (AHSC) to provide industry with a one-stop source of information and support when undertaking research and development activities in the NHS in Wales. A dedicated industry team is in place to ensure the delivery of a quality Health Research Wales service. The team works across Wales to provide the service, facilitating the effective delivery of clinical research within the NHS. Health Research Wales has the support and commitment of a wide range of partners across Wales, including the National Health Service, academia and the Welsh Government.

HealthTech and Medicines Knowledge Transfer Network

Knowledge Transfer Network

Phone: +44 (0)1223 899000 Email: sue.dunkerton@healthktn.org Web: connect.innovateuk.org/web/ healthktn

The HealthTech and Medicines Knowledge Transfer Network (Health KTN) is dedicated to accelerating innovation and technology exploitation in the health industries sector. This includes the Medical Biotechnology, Medical Technology, Diagnostics and Pharmaceutical industries. The Health KTN will help you connect with other organisations, both within and outeith your sector, to catalyse innovation. These could include companies, the science and clinical base, and the public sector. It does this through running events and workshops for practitioners and innovation leaders in its priority areas and creating awareness of funding vehicles at the public-private sector interface.

Ty Menai Parc Menai Business Park Fordd Penlan Bangor Gwynedd LL57 4HJ Tel: +44 (0)1248 675093 Email: info@hpcwales.co.uk Web: www.hpcwales.co.uk

High Performance Computing (HPC) Wales is Wales’ national supercomputing service provider. Host to the UK’s largest distributed supercomputing network, HPC Wales provides businesses and researchers with access to world-class technology, support, and training. High performance computing (HPC or ‘supercomputing’) has the capacity to handle and analyse massive amounts of data at high speed, and to model and solve highly complex problems. A partnership between the universities in Wales, HPC Wales is funded by the European Regional Development Fund through the Welsh Government, the UK Department for Business, Innovation and Skills, and the Higher Education Funding Council for Wales.

HealthTech and Medicines

HPC Wales

Attending: Mrs Georgina Lewindon Marketing and Communications Manager Mr John Walsh Business Development Manager

29

SPRING 2013 BIOWALES BROCHURE

IBI Nightingale

Attending: Mr Mark Drane Studio Director Mr Andrew Street Architect

The Old Convent The Walk Cardiff South Glamorgan CF24 3AG Tel: +44 (0)29 2044 8900 Email: mark.drane@ibigroup.com Web: www.ibi-nightingale.com

IBI Nightingale is a leading design practice with an international reputation for thought leadership. Our strong design research ethos is underpinned by the work of IBI THiNK. THiNK is responsible for encouraging, capturing and developing the intellectual capital vested in IBI’s projects, people and processes. Promoting this ‘cradle to cradle’ approach means our clients benefit from a continually improved solution. We also conduct leading-edge research in collaboration with university, healthcare and pharma partners. For example, our ‘4 Labs 4 Cities’ world-wide benchmarking survey will allow us to optimise laboratory design, adding value to future scientific investment.

IBI Group. Global Intelligence. Local Knowledge.

Insteng Process Automation

Attending: Mr Aidan Farrelly Marketing and Business Development Specialist Mr Dan Evans Service Manager

Unit 3 Moy Road Industrial Estate Taffs Well Cardiff South Glamorgan CF15 7QR Tel: +44 (0)2920 815 000 Email: enquiries@insteng.co.uk Web: www.insteng.co.uk

Insteng Process Automation specialises in process measurements, analytical products for industrial and environmental applications, control systems and customised solutions. Representing some of the leading names in the industry, Insteng can provide unrivalled service and a single source of supply for your instrumentation needs. Products and systems from leading international instrumentation suppliers encompass areas including temperature, level, pressure, flow, imaging, infra-red temperature, humidity, speed, density, telemetry, calibration and gas and liquid analysis, and thermography. Our main activities lie in the following industries: steel, chemical, pharmaceutical, general industry support, plant supplier, food and beverage, energy and environmental, electrical manufacturers and distributors.

College of Medicine Swansea University Singleton Park Swansea SA2 8PP Tel: +44 (0)1792 513705 Email: ilscommunications@swansea.ac.uk Web: www.swan.ac.uk/ils/home/

The Institute of Life Science (ILS) houses over 200 research specialists, 15 companies and around 30 affiliate companies. It has four floors of open plan laboratories, a Clinical Trials Research Facility, an Imaging Facility, the Centre for NanoHealth, an MRC e-health Centre of Excellence, the EPSRC National Mass Spectrometry Service Centre, and business and conference facilities.

Clinical Trials are run jointly with ABMU Health Board specialists. The ILS is actively seeking new research collaborations, business partnerships and clients. We look forward to meeting you at BioWales 2013.

Institute of Life Science

Attending: Ms Sian Newman Communications Manager Ms Stephanie Lee Marketing Manager

30

Institute of Translation, Innovation, Methodology and Engagement (TIME)

Attending: Dr Christopher Marshall Operations Director, Wales Research & Diagnostic PET Imaging Centre Mrs Sarah Hatch Innovation & Engagement Manager

School of Medicine Cardiff University Heath Park Cardiff South Glamorgan CF14 4XN Phone: +44 (0)2920 742104 Email: edwardske4@cf.ac.uk Web: medicine.cf.ac.uk/translationinnovation-engagement

There are many components of the TIME Institute, including three Clinical Trials Units, Wales Institute for Forensic Medicine, Wales Research and Diagnostic Positron Emission Tomography Imaging Centre (PETIC), and Central Biotechnology Services (CBS). Exhibiting are CBS, a BS EN ISO 9001:2008 accredited Technology Facility offering postgenomic and cell analysis/imaging platforms to Cardiff University researchers and external organisations, and PETIC, which provides the focus for cutting edge research and teaching in PET for a network of higher education institutions across Wales and the UK, as well as delivering a clinical service for patients in Wales.

Lumen House Library Avenue Harwell Oxford Didcot Oxfordshire OX11 0SG Tel: +44 (0)7794 205695 Email: paul.bevan@ja.net Web: www.ja.net

Janet provides a world-class network infrastructure to meet the needs of the UK’s research and education community. With nearly 30 years’ uninterrupted service, Janet is building the next generation of the Janet infrastructure – Janet6. The new Janet6 infrastructure will provide continued support for the UK’s knowledge economy whilst ensuring best value for our customers. Janet recognises the importance of clinical research, education, and innovation to its community and to Wales and UK plc and supports collaborative work in this area for example through its facilitation of the NHS-HE Forum and the NHSHE Connectivity Project.

Inmobiliaria Siboney PALCO, Edificio 1ra y B Piso 11, Bloque A y C, Plaza de la Revolución, La Habana, Cuba Phone: (07) 8333995- (07) 8371352 Email: labiofamsa@labnet.com.cu Web: www.labiofamcuba.com

The Enterprise Group LABIOFAM SA is a Cuban state-owned enterprise with over 20 years’ experience in Cuba and worldwide. They specialise in the production, distribution and commercialisation of natural products for human health, veterinary products and biopesticides for the control of vectors spreading diseases such as dengue and malaria. LABIOFAM SA develops joint enterprises with national and foreign companies, ranging from joint ventures to cooperative production and technology transfers. Its most outstanding achievements include new natural products for the treatment of oncological, respiratory and digestive diseases and its presence for over 10 years in different African countries, applying successful programs in the control of such diseases as malaria and dengue.

Janet

Attending: Mr Paul Bevan Customer Engagement Manager, Wales Mr Malcolm Teague NHS-HE Coordinator

LABIOFAM SA

Attending: Ms Dayami Perez Expert Marketing Mr Oniel Díaz Castellanos Export Manager

31

SPRING 2013 BIOWALES BROCHURE

MediWales

Attending: Ms Debbie Laubach Operations Manager Mr Gwyn Tudor Forum Manager Ms Charlotte Tyson Project Coordinator

7 Schooner Way Atlantic Wharf Cardiff South Glamorgan CF10 4DZ Phone: +44 (0)29 2047 3456 Email: info@mediwales.com Web: www.mediwales.com

MediWales has been active for over twenty years and is the representative body for the life sciences sector in Wales. MediWales is in regular communication with over 1700 contacts, and currently has 140 members.

Supported by the Welsh Government, MediWales is owned by its members and led by directors drawn from senior industrialists and academics in Wales.

MediWales generates a unique environment for networking, collaboration and communication between industry, higher education and health service members. This is delivered through an active schedule of seminars, events and publications, supported by the MediWales website and maintained via constant communication with members and stakeholders. From this pivotal role, MediWales is able to represent both its members and the wider sector to governmental and international partners.

MediWales will be representing the HealthTech and Medicines Knowledge Transfer Network at their BioWales stand this year.

NHS Wales Informatics Service (NWIS)

Attending: Mrs Jan Sparks Engagement Officer Mr Brent Varley Pathology ICT Lead

12th Floor Brunel House 2 Fitzalan Road Cardiff South Glamorgan CF24 0HA Tel: +44 (0)2920 500500 Email: nwisenquiries@wales.nhs.uk Web: www.wales.nhs.uk/nwis

NHS Wales Informatics Service leads the way in NHS Wales IT in partnership with Health Boards and Trusts. We bring together the strategic development of Information Communications Technology (ICT), the delivery of operational ICT services, and information management. We have a national role to support NHS Wales and make better use of skills and resources. We are leading on the new integrated digital information services.

PDR – The National Centre for Product Design + Development Research

Attending: Mrs Julie Stephens Commercial Manager Mr Jarred Evans Commercial Director

Western Avenue Cardiff South Glamorgan CF5 2YB +44 (0)29 2041 6725 Email: info@pdronline.co.uk Web: www.pdronline.co.uk

PDR is a world renowned design consultancy and research centre offering comprehensive product development support. PDR has considerable experience in medical device development in all classifications, from simple disability devices and rehabilitation equipment through to complex diagnostic tools and drug delivery systems. Device development at PDR is undertaken through a proven design methodology that employs the latest design and manufacturing analysis tools and technologies to produce robust, compliant and commercially successful solutions.

9978 Erie Stream Way Las Vegas, NV 89148 Phone: (702) 448-2660 Email: info@pemfsystems.com Web: www.pemfsystems.com

PEMF Systems, Inc. manufactures the world’s most advanced pulsed electromagnetic field therapy devices. Stop at our exhibit and you will see amazing improvements in pain, range of motion and inflammation in people using our device.

PEMF Systems Attending: Mr Michael Davis CEO Miss Trudy Rich

32

Penn Pharma

Attending: Mr Wayne Deans Business Development Support Services Manager Ms Aldyth Smith Head of New Product Introduction and Customer Service

23-24 Tafarnaubach Industrial Estate Tredegar Gwent NP22 3AA Phone: 01495 711 222 Email: enquiries@pennpharm.com Web: www.pennpharm.co.uk

Penn has become a trusted supply partner of many of the top healthcare companies during our 30+ years of trading. We are proud of our reputation for providing reliable specialist services across the world. Penn has seen a growth in the number of potent pharmaceutical products and in response we have invested in an expansion of our current resources to meet this demand.

Our mission is to become the partner of choice for the development, testing, and supply of pharmaceuticals requiring the very best in GMP facilities backed by an enviable team of scientists, engineers, and supply chain professionals.

Potters Yard Cross Hayes Malmesbury Wiltshire SN16 9BE Phone: +44 (0)1666 826540 Email: info@pleasetech.com Web: www.pleasetech.com

PleaseTech’s flagship product, PleaseReview, is a proven collaborative review and co-authoring solution for Microsoft Word and other document types, facilitating controlled, simultaneous and secure collaboration for the review and editing of documents. Document review and co-authoring is a critical business issue consuming considerable resources across organisations. PleaseReview solves this by offering control, management and metrics to the review, accommodating online and offline reviewers and enabling secure collaboration with external partners. PleaseCompose is a structured authoring and content reuse solution for Microsoft Word, making it easy to create new documents using predefined templates and pre-approved content.

PleaseTech

Attending: Mr David Cornwall CEO Mr Dave Sheppard Business Development Manager

PRA Llys Tawe Kings Road SA1 Swansea Waterfront Swansea SA1 8PG Phone: +44 (0)1792 525628 Email: phillipsemma@prainternational.com Web: www.prainternational.com Attending: Mrs Emma Phillips Senior Manager, Clinical Data Mrs Charlotte Miles Senior Recruitment Specialist, EAPA

As a leading contract research organisation, PRA is transforming clinical trials through our people, innovation and transparency. We combine therapeutic and operational expertise with local knowledge to serve clients across all phases of drug development. Our successful history of helping to bring new drugs to market demonstrates our successful approach to clinical research.

PRA supports our global reach through flexible and reliable service delivery.

Thanks to our advanced technological tools and finely tuned systems, we achieve seamless delivery and operational transparency throughout our organisation. PRA’s dynamic services and forward-thinking approach are making a difference to healthcare patients worldwide.

33

SPRING 2013 BIOWALES BROCHURE

Sharp Clinical Services

Attending: Mrs Gemma Maust Business Development Manager Mrs Rachel Curran Commercial Manager

Waller House Elvicta Business Park Crickhowell Powys NP8 1DF Tel: +44 (0)1873 812182 Email: ian.morgan@sharpclinical.com Web: www.sharpclinical.com

Sharp Clinical Services is part of United Drug, who provides commercialisation solutions to international healthcare companies. Operating from three divisions, we specialize in supply chain, packaging, sales and marketing, medical and regulatory services operating in five major international markets.

For over 20 years, Sharp Clinical Services has provided end-to-end drug product development and manufacturing services over increasingly complex research & development, packaging, and distribution clinical study protocols for multinational and domestic trials. Our experienced project management and functional teams bring together years of unparalleled experience in producing and managing your clinical supply chain across the globe under the highest quality standards spanning Good Manufacturing Practices (cGMP) or any other international regulatory compliance. With Sharp Clinical Services’ global footprint, access to the world markets just became easier from clinical production and distribution to comparator sourcing and QP services.

Merthyr Tydfil Industrial Park Pentrebach Merthyr Tydfil CF48 4DR Phone: 01443 690977 Email: contact@simbec.com Web: www.simbec.com

Simbec Research provides contract clinical trial services to the international pharmaceutical and biotechnology sectors, developing new medicinal products including devices and diagnostics. We have been servicing international pharmaceutical, biotechnology and related drug companies for over 35 years and specialise in First-in-Human studies of new molecular entities and biologicals. Trials conducted range from Phase I studies in healthy subjects through to Phase II trials in patients. All services are on one site, including full bioanalytical backup, Central Laboratory and related support services. Simbec is one of a select group of companies that has received Supplementary Accreditation from the MHRA.

Simbec Research

Attending: Miss Lydia Vitolo International Account Manager Miss Ceri Edwards Project Management & Biometrics Manager

Swansea University - Centre for NanoHealth (CNH)

Attending: Mrs Jennifer Walker Project Co-ordinator, CAN Mr Sridhar Govindarajan Research Assistant, NMH

34

Institute of Life Science - ILS2 Swansea University Singleton Park Swansea SA2 8PP Phone: +44 (0)1792 602983 Email: m.p.elwin@swansea.ac.uk Web: www.swan.ac.uk/nanohealth

The Centre for NanoHealth (CNH) is a joint initiative between Swansea University’s colleges of Engineering, Medicine and Science and the Abertawe Bro Morgannwg University Health Board. The CNH offers opportunities to work at the interface between Engineering Biomedical Science and clinical delivery through access to a wide range of academic and clinical expertise and partnerships, and state of the art nanotechnology and biomedical R&D facilities. Together with partner projects, Celtic Alliance for NanoHealth (CAN) and Nano & Micro Technologies for Healthcare (NMH), the CNH project is focussed on working with Welsh & Irish companies but welcomes collaborations and offers open access to its facilities to any interested organisation.

SymlConnect Ltd & MiTAC Europe

Attending: Dr Sabarna Mukhopadhyay CEO, SymlConnect Mr Jamie Young UK Sales Manager, MiTAC

Room 503 & 504 Institute of Life Sciences 2 Swansea University Singleton Park Swansea SA2 8PP Phone: +44 (0)1792 606525 Email: sabarna@symlconnect.com Web: www.symlconnect.com

SymlConnect has partnered with MiTAC Europe, a subsidiary of global ICT company MiTAC. SymlConnect has developed standards based, secure, interactive healthcare information exchange applications on MioCare tablets specifically designed for healthcare professionals. Bi-directional information transaction from existing systems and protocols contributes to significant time and cost savings to organisations. Authenticated log-in; secure, upto-date information access; new data input at-the-point-of-care; priority alerts; clinical care pathway reminders; dashboard-style reporting; auditing; monitoring; and management are all customised on this framework to create a user friendly solution for users.

UCLB Devices The Network Building 97 Tottenham Court Road London W1T 4TP Phone: +44 (0)207 679 9000 Email: m.bardwell@uclbdevices.com Web: http://www.uclbdevices.com

UCLB Devices specialises in the commercial and technical evaluation of all classes of medical devices, scientific instruments and in vitro diagnostics.

We offer a unique service within an ISO 13485 compliant environment which encompasses commercial and technical evaluation, risk assessment, design, development, prototyping, regulatory evaluation, CE Marking, manufacture, clinical effectiveness studies and placing products on the market.

Belgian Volition SA - Centre Technologique Rue du Séminaire, 20A Namur BE-5000 Belgium Phone: +32 81 72 56 50 Email: info@volitionrx.com Web: www.volitionrx.com

Volition’s proprietary Nucleosomics® technology enables access to epigenetic information via its range of NuQ® assays. This allows simple ELISA based profiling of epigenetic features (histone modifications, variants, DNA modifications and nucleosome-protein adducts) of intact nucleosomes in cell culture, blood and other biofluids. We are developing blood tests for the detection and prognosis of early stage cancer, during which patients’ survival chances are higher. We have external trials underway in colon, prostate and breast cancer as well as internal trials with samples provided by the Wales Cancer Bank. NuQ® assays are also available for sale for research use only.

Room GTB2_1 Main Building University Hospital of Wales Heath Park Cardiff South Glamorgan CF14 4XN Phone: +44 (0)2920 743243 Email: walescancerbank@cardiff.ac.uk Web: www.walescancerbank.com

The Wales Cancer Bank (WCB) consents patients in 12 hospitals around Wales and collects tissue and blood from 23 different tumour types. The samples are collected, stored and processed to standard operating procedures and all samples are quality controlled. Researchers worldwide can apply for access to samples. WCB is licensed by the Human Tissue Authority and has ethics approval from the REC for Wales as a research tissue bank. Bespoke collections can be undertaken and WCB also hosts translational samples from UK-led clinical trials as well as offering digital slide imaging, tissue microarray and lasercapture microdissection services.

Attending: Dr Max Bardwell General Manager Mrs Jaspal Kaur-Griffin Senior Project Development Manager

VolitionRx

Attending: Mr Thomas Bygott Sales and Marketing Director Dr Mark Eccleston External Collaborations Manager

Wales Cancer Bank

Attending: Dr Alison Parry-Jones Manager Miss Sarah Phillips Project Officer

35

SPRING 2013 MEDIWALES REVIEW

This year’s MediWales Innovation Awards celebrated the fantastic achievements of life science companies and individuals from the NHS in Wales. A priority sector in a tough economy,

MEDIWALES INNOVATION

Welsh industry’s innovative partnerships with the NHS and academic institutions significantly contribute to the

2012

health and wealth of Wales.

The 300-guest Awards Dinner, sponsored by the National Institute for Social Care and Health Research (NISCHR), Abel & Imray, Geldards LLP, GX Group, eHealth Industries Innovation Centre (ehi2), and Sony UK Tec, was held at Cardiff City Hall on Tuesday 11th December with an audience of senior industry, NHS and government representatives.

Baroness Ilora Finlay of Llandaff opened the ceremony presenting the Industry Innovation Award, with a further six prestigious awards presented to industry, and two to NHS Wales departments.

36

The Innovation Award was won by single-use, surgical instrument manufacturer DTR Medical. Their high quality products and exceptional service provide excellent clinical value to hospitals and clinics. DTR Medical has used metal injection moulding to create a cost-effective, singleuse instrument for cervical biopsies. The product is expected to have a significant impact both in the UK and overseas, with the current customer base predicted to grow by over 300% in the next 3 years. This award was sponsored by Cardiff Medicentre.

The Start-up Award was picked up by Rogue Resolutions for their success in the first two years of trading. The company provides integrated solutions for neuroscience, which include best-in-class systems for neuromodulation, brain imaging and neuronavigation.

Established in 2010, Rogue Resolutions aims to increase direct contact with end users and streamline the crossover of applications from research to clinical environments. Rogue Resolutions is researching new products and markets and is currently expanding operations into the USA. This Award was sponsored by Finance Wales.

For the third year running Chromogenex Technologies has won the Export Achievement Award. Chromogenex manufactures light and laser-based systems for the medical and cosmetic market, offering effective, non-invasive treatments for conditions such as acne and scarring, fat reduction, facial rejuvenation and hair removal.

Chromogenex successfully distributes products in Africa, Australia and Brazil, with the USA accounting for 60% of global sales. Chromogenex is currently focusing on the high-growth export markets of Brazil, Asia Pacific and Russia. This award was sponsored by Welsh Government’s life sciences sector team.

Invacare was recognised in the Outstanding Achievement Award.

Invacare respiratory services produces innovative, patient-friendly oxygen devices designed to give patients the independence prevented by standard delivered oxygen modalities. The company has undergone considerable growth in this area, with an outstanding tenfold increase in turnover between 2011 and 2012. Invacare has worked with both the NHS and oxygen contractors, and their efficient non-delivery products have successfully been introduced into the Scottish NHS with excellent patient feedback. Invacare has also partnered with Dolby Vivisol to aid distribution across England and Wales. This award was sponsored by Broomfield and Alexander.

A true industry–NHS collaboration was recognised this year, with Kodit winning the Partnership with the NHS/Academia Award for their collaborative project with Chelsea and Westminster Hospital, Edinburgh Napier University, and Imperial College London. A Wales-based software design house, Kodit develops strategic and standard platforms for the mobilisation of healthcare systems. Their product, CAREmagic, addresses specific sets of health procedures, allowing users to generate auditable proof of outcomes whilst also increasing efficiency and reducing cost. This Award was sponsored by Wynne-Jones IP.

37

SPRING 2013 MEDIWALES REVIEW

The NHS Partnership with Industry Award went to Aneurin Bevan Health Board’s Intellectual Property Group for their collaboration with E2L design consultancy to produce the ‘Easy Vein Access’ medical device. The product increases the size and accessibility of veins prior to cannulation, improving the success rate of insertion and so reducing patient distress and nursing time. Currently in its pilot trial stages, the device could reduce NHS costs considerably through savings in consumables and waste disposal. This Award was sponsored by the Welsh Government’s National Institute of Social Care and Health Research (NISCHR).

The Judges’ Award was won by GE Healthcare, which provides expertise and tools for research of cells and proteins, drug discovery research, as well as tools to support large-scale manufacturing of biopharmaceuticals. Key target market sectors are the early stages of drug discovery programmes, in particular high-throughput drug screening, metabolism and distribution studies. This Award was sponsored by Teamworks Design and Marketing.

38

The Innovation within the NHS Award was won by The North Wales Department of Medical Physics, part of the Betsi Cadwaladr University Health Board. The department provides scientific and technical support for patient services based on high-technology medicine. The team designed and manufactured the CelT phantom test tool, which provides realistic, effective testing of diagnostic CT scanners. Unlike existing phantoms, it forces the scanner to modulate its activity and behave as it would for a patient. This innovative idea holds great potential for expansion to Europe and beyond. This Award was sponsored by the Welsh Government’s National Institute for Social Care and Health Research (NISCHR).

A new addition to our awards this year, the ehi2 Innovation Award for Digital Technology in Health, was won by GP Commissioning Solutions, a provider of advanced health analytics with over 20 years’ experience in E-health. Their innovation, the Health Intervention Toolkit (or HINT), uniquely combines predictive risk modelling, gaps in care and medicines management to identify patients at risk. HINT provides clinicians with a targeted group of patients and has demonstrated benefits in both efficiency and patient outcomes. This Award was sponsored by the eHealth Industries Innovation Centre, (ehi2).

H E A L T H

A N D

W E A L T H

C O N F E R E N C E

The first of many, MediWales’ UK HealthTech Conference: Health and Wealth took place on 11th December in Cardiff’s City Hall The latest annual instalment of UK Government’s Department for Business Innovation and Skills’ (BIS) Strength and Opportunity Report was officially launched at the event, which gives a thorough look at the landscape of the UK medical technology, medical biotechnology, industrial biotechnology and pharmaceutical sectors.

A collaborative event, MediWales partnered with Welsh Government, the Association of British Healthcare

Industries, Medilink UK, the HealthTech and Medicines Knowledge Transfer Network, One Nucleus, UK Trade and Investment, and the UK Lifescience Industry magazine to develop the conference.

The one-day event, attended by over 200 delegates, covered technology and innovation adoption, novel technologies and healthcare trends, and funding and investment. The programme boasted speakers including Baroness Ilora Finlay, Mirella Marlow from NICE, Michael

Kreuzer OBE from the Association of British Healthcare Industries, and Helen Kuhlman from the Technology Strategy Board.

Seminars focussed on funding, regulation and accessing clinical expertise, whilst an exhibition area allowed numerous organisations to engage with delegates.

Following the overwhelming success of the first UK HealthTech conference, look out for news of MediWales’ next UK wide conference in 2013!

Unrivalled Connectivity The MediWales-commissioned Welsh life science sector film, ‘Unrivalled Connectivity’, was launched at the Innovation Awards.

Sponsored by Geldards LLP, GX Group, Abel and Imray, eHealth Industries Innovation Centre (ehi2), and Sony UK Tec, the film depicts the unrivalled connectivity between Wales’ industry, academic, NHS and professional services organisations, which enables the fast, effective development of innovative healthcare solutions.

Watch at www.mediwales.com

39

SPRING 2012

l

MEDIWALES REVIEW

1

2

Plan healthcare

MARKETING MATERIALS

healthcare osphealthcare.com

DIGITAL MEDIA

EXHIBITIONS

MEETINGS AND EVENTS

MOA AND VIDEO PROGRAMMES

I111_OSP_BioWales Advert_220213.indd 1

2/22/2013 12:41:51 PM

3

4 lifesciences@geldards.com

0844 736 0006

healthcare www.osphealthcare.com

healthcare osphealthcare.com

COMMERCIAL HANDS ON, DRIVE TO GET THINGS DONE AND

WITH A

Legal 500 2012 Geldards is one of the country’s leading regional law firms. Our clients, in both the private and public sectors, trust us to give them high quality legal advice that is practical, commercially-minded and value for money.

Our dedicated healthcare and life sciences team has a strong track record in dealing with medical technology, know-how licensing, research & development collaborations, commercial contracts and commercial & intellectual property disputes.

We can generate: commercial success, financial rewards, and plasma...

We take brilliant ideas and turn them into commercial reality.

Our hand-held Plasma Generator is the first of its kind and leads the medical world in fast wound sterilisation.

It’s another example of GX’s credentials at the forefront of design engineering.

Do you have a brilliant idea and need some help turning it into a commercial reality?

Maybe you need some design and engineering flair to bring a product to a new market?

Visit Claire and Mark at BioWales 2013 Our Services: Electronics

Optronics

It’s what we do. As one of the UK’s leading technology and innovation companies we take a multidisciplinary and holistic approach to turn brilliant ideas into commercial realities.

Industrial Design

Value Engineering

Mechanical Engineering

GPS/GPRS Tracking

Software Design

RFID

Whether it’s a hand held, fast Plasma Generator for sterilising wounds or a world-first Model Gut for testing the actions of drugs and foods, we make it possible.

Rapid Prototyping

Regulatory Support

SCADA/PLC Systems

Microfluidics

The Mayfield | Usk | Monmouthshire | NP15 1SY | UK

t +44 (0)1291 673 437 | info@gxgroup.com | www.gxgroup.com

Make it possible

THE EXAMINATION SCHOOLS, OXFORD 4TH & 5TH MAY 2013

SPRING 2013 BIOWALES BROCHURE

NEUROENHANCEMENT

WALES medica special

CONFERENCE & WORKSHOP 2013

The Magstim Neuroenhancement Conference & Workshop is the latest in a series of ‘TMS Summer Schools’ organised by Magstim and leading academics in the field.

ACADEMIC ORGANISERS: VINCE WALSH, CHARLOTTE STAGG & SVEN BESTMANN

FOR THE LATEST VERSION OF THE PROGRAMME, PLEASE VISIT: www.magstim.com FOR MAGSTIM EVENT UPDATES FOLLOW @neuromodulation

Production and distribution is supported by partners including:

United Kingdom

INDUSTRY

● iNets South West Biomedical ● MediWales ● Medilink East Midlands ● SEHTA ● Medilink West Midlands ● Medilink Yorkshire & Humber ● ABHI ● HealthTech and Medicines

KTN

● One Nucleus ● Scottish Enterprise ● Medilink South West ● Medilink North West

Distributed to 38,000 named individuals with an estimated total readership of 100,000

Well informed. Well read.

News, developments and analysis from the magazine at the heart of the UK Lifescience Industry. Published in partnership with Medilink UK and its partner organisations who are in daily contact with leading innovators, UK Lifescience Industry provides: ● Cutting edge analysis ● Leading scientific opinion ● A perfect platform for advertising ● Print and digital formats

PUBLISHED IN PARTNERSHIP WITH MEDILINK UK

Make sure you book your place Contact: charlotte@uklifescienceindustry.com

or call +44(0) 29 2047 3456

Improve your work flow with DTR MEDICAL

● ● ● ●

Single-use High quality Excellent service Delivers the clinical value you need

+44 (0)1792 797910 www.dtrmedical.com Twitter: @dtrmedical DTR SPECIALITIES: GENERAL & VASCULAR

Your sterile single-use solution, without compromise ENT/MAXFAX

GYNAECOLOGICAL

NEUROSURGICAL

ORTHOPAEDIC

+ WWW.PDRONLINE.CO.UK

WALES medica special

MEDICAL DEVICE DESIGN æ ROBUST PRODUCT + ENGINEERING DESIGN æ USABILITY + HUMAN FACTORS STUDIES æ INTERACTION + USER INTERFACE DESIGN æ ADVANCED RAPID PROTOTYPING æ LOW VOLUME RAPID MARKET ENTRY MANUFACTURE æ MANUFACTURING + NPI SUPPORT æ IN HOUSE CAPABILITY DEVELOPMENT æ KNOWLEDGE TRANSFER

THE NATIONAL CENTRE FOR PRODUCT DESIGN + DEVELOPMENT RESEARCH

PDR WESTERN AVENUE CARDIFF UK CF5 2YB

T +44 (0)29 2041 6725 F +44 (0)29 2041 6973 E INFO@PDRONLINE.CO.UK

+ WWW.PDRONLINE.CO.UK